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Evaluation of Analgesic and Anticonvulsant Activity of Hydroalcoholic Extract of 
Costus Pictus Leaves in Wistar Albino Rats 
Abstract 
Background:  
Oxidative stress has a significant role in the development, progression and 
treatment refractoriness of various pathophysiological conditions including pain and 
epilepsy. Costus pictus D. Don commonly referred as insulin plant has proven antioxidant 
property. Phytochemical studies of this plant have confirmed the presence of potent 
antioxidants mainly flavonoids. With huge evidence in literature for the role of oxidative 
stress in pain and epilepsy, this study was planned to evaluate the analgesic and 
anticonvulsant activities of hydroalcoholic extract of Costus pictus leaves in animal 
models which have not been studied so far.  
Aims and objectives:  
To evaluate the analgesic and anticonvulsant activities of hydroalcoholic extract of 
Costus pictus leaves in Wistar albino rats. 
Materials and methods: 
A total of 78 healthy Wistar albino rats (180-250 g) of either sex were included in 
the study and divided into 13 groups (Group I to XIII) consisting of 6 animals each. The 
hydroalcoholic extract of Costus pictus leaves [CP-HALE] was prepared using cold 
maceration method and was tested at two doses (200 mg/Kg BW and 400 mg/Kg BW) 
given orally.  
Central analgesic activity was tested using tail clip and hot plate methods 
[standard - morphine 5 mg/Kg BW i.p.] and peripheral analgesic activity was evaluated 
using writhing test [standard – morphine (5 mg/Kg BW i.p.) and diclofenac sodium (12.5 
mg/Kg BW orally)]. Anticonvulsant activity was evaluated using Maximal Electroshock 
induced Seizure (MES) model [standard - phenytoin 10 mg/Kg BW; i.p.] and 
pentylenetetrazole (PTZ) model [standard - sodium valproate 400 mg/Kg BW i.p.]. 
 
 
Results:  
With CP-HALE 400 mg/Kg BW, there was a significant increase in reaction time 
in tail clip and hot plate methods. There was also significant reduction in total number of 
writhes and the percent inhibition of writhes [82.87%] was comparable to the standard 
drugs.  
MES model revealed that at both the doses (200 mg/Kg BW and 400 mg/Kg BW) 
of CP-HALE there was 100 percent protection against tonic hind limb extension (THLE). 
A significant decline in the seizure scores was also seen at 400 mg/Kg BW.  
In PTZ model, both the doses of CP-HALE increased the time for onset of 
seizures and decreased the duration of seizures which were higher and significant at 400 
mg/kg BW and at this dose there was also a significant reduction in the total number of 
seizures (in one hour). There was no significant decline in the seizure scores at both the 
test doses (200 mg/Kg BW and 400 mg/Kg BW).  
Conclusion:  
The hydroalcoholic extract of Costus pictus leaves possess significant analgesic 
and anticonvulsant activity in Wistar albino rats at the dose of 400 mg/Kg BW. 
     
Key words: Pain, Seizures, Epilepsy, Oxidative stress, Antioxidant, Insulin plant, 
hydroalcoholic extract 
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1. Introduction 
The practice of using natural products in therapy is well established since 
ancient times. Products from natural sources also serve as lead compounds 
for design and synthesis of new drugs. Plants contribute for around 25% of 
the drugs used world-wide and still remains the major resource for new drug 
development.
Costus pictus D. Don (syn. Costus mexicanus Leibm.), commonly called 
as insulin plant,
1 
2 has its origin in Mexican moist forests and hills.3 It has 
gained popularity in India recently. It is a perennial herb3 which is grown as 
an ornamental plant in South Indian gardens, particularly in various parts of 
Kerala.2 It belongs to the family Costaceae2 and is very popular for its 
antidiabetic property for which its fresh leaves are chewed and eaten raw by 
diabetic people.4 There are several previous studies which have 
demonstrated the various medicinal properties of Costus pictus such as 
antidiabetic,4,5 antihyperlipidemic,5 antibacterial,6,7 anthelmintic,2 analgesic,3 
antioxidant5,8,9 and anticancer activity.10 Costus pictus extract (500-2000 
mg/day in humans, orally) has been patented for glycemic control in diabetes 
mellitus.3 In Cuba, the decoction of its fresh leaves and stems has been a 
traditional therapy for various urinary disorders and also used as a pain relief 
in renal colic.3
 Pain accompanies almost all pathological conditions and is an unpleasant 
sensation often accompanied by anxiety and an urge to terminate the feeling 
immediately.
  
11,12 It often requires rapid and effective treatment with 
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analgesics. Commonly used analgesics are opioids and non-opioids 
[Nonsteroidal Anti-Inflammatory Agents (NSAIDs) and antipyretic-
analgesics].12 Opioids remain the most potent and reliable centrally acting 
analgesics and are considered the mainstay in pain management.11,12 Their 
use is limited by its side effects and addiction liability.11 The NSAIDs  which 
are usually used for mild to moderate pain is also limited by its adverse 
effects, including gastrointestinal, renal and cardiac effects.13 There is still a 
growing need for an effective analgesic which is better tolerated. A study 
using mice models has proved a significant and dose-dependent peripheral 
and central analgesic activity of Costus pictus decoction.3 
Epilepsy is a clinical condition in which an individual presents with 
recurrent abnormal or excessive neuronal activity due to a chronic 
underlying pathology.
Hence, it is 
rational to carry out further studies to demonstrate its analgesic studies using 
different animal models to validate the evidence. 
14,15 Epilepsy occurs in various forms and multiple 
causes underlie its pathogenesis. 5-30 persons per 1000, is the estimated 
prevalence for epilepsy.14 The outcome of treatment is largely based on 
selection of an appropriate therapy. Several antiepileptic drugs that are 
currently available control seizure activity rather than treating the underlying 
disorder.15 Their usefulness is limited due to their toxicity and development 
of drug resistance.14,15,16 The search for more effective and less toxic 
antiepileptic drugs still remains valid. There is a strong correlation between 
oxidative stress and pathogenesis of epilepsy.17,18 It is thus rational to 
  Introduction 
Page | 3  
 
hypothesize that Costus pictus plant extract which has significant antioxidant 
activity5,8,9 
There is a growing interest on the therapeutic potential of natural products 
in recent years and pharmacological screening of plants is considered as a 
suitable approach to new drug development.
might be beneficial in the treatment of epilepsy. Also, there are 
no studies so far to evaluate the analgesic and anticonvulsant activity of 
hydroalcoholic extract of Costus pictus leaves.  
1 In the present study, 
hydroalcoholic extract of Costus pictus leaves were chosen to explore its 
analgesic and anticonvulsant properties which have not been screened so far.   
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2.1 Hypothesis 
Hydroalcoholic extract of Costus pictus leaves possess analgesic 
and anticonvulsant properties. 
2.2 Justification  
Oxidative stress generates free radicals18  and has been implicated 
in the development,  progression and treatment refractoriness of various 
pathophysiological conditions including pain19,20 and epilepsy.17,18,21 
Antioxidants are endogenous or exogenous substances which act by 
reducing free radical formation, free radical scavenging or removal of 
free oxygen.22 Oxidative stress and mitochondrial dysfunction  is 
implicated in neuronal death, hence has important role in the onset and 
maintenance of seizures.17,18  It was shown that partial prevention of 
induced seizures is possible with the use of antioxidants.18 Currently 
available analgesics and antiepileptic drugs, have limitations such as 
toxicity, teratogenicity, drug resistance, and significant pharmacokinetic 
interactions.15 Hence, antioxidants may be an important adjunct to 
conventional therapies17  and also they serve as a direction for 
development of novel antiepileptic drugs.
The antioxidant property of Costus pictus leaves
18 
5,8,9 and also its 
various other parts2,6  has been proved by several previous studies. 
Various studies on the phytochemistry of Costus pictus have revealed 
that it contains compounds such as coumarins, flavanoids, phenols and 
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lactones which are responsible for its antioxidant6,8 and analgesic 
properties.3  It was also shown in an earlier study that the dry 
hydroalcoholic extract of Costus pictus leaves possessed highest 
antioxidant activity.9 A dose dependent central and peripheral analgesic 
effect of Costus pictus decoction has been proved in mice models.3 
There are no studies so far to evaluate the analgesic and 
anticonvulsant activities of hydroalcoholic extract of Costus pictus leaves 
in animal models. With a large body of evidence for the role of oxidative 
stress in pain and epilepsy, it is thus rational to evaluate the analgesic and 
anticonvulsant effects of Costus pictus which has proven antioxidant 
property. 
There 
is a need for demonstrating analgesic activity in different animal models 
for validating the evidence.  
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3. Aims and Objectives: 
 
To evaluate the following activities of hydroalcoholic extract of Costus 
pictus leaves in Wistar albino rats 
i. Central analgesic activity using tail clip and hot plate methods 
ii. Peripheral analgesic activity using 4% NaCl induced writhing test 
iii. Anticonvulsant activity on electrically induced seizures  
iv. Anticonvulsant activity on pentylenetetrazole induced seizures  
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4. Review of Literature 
4.1 Pharmacognosy of Costus pictus 
Pharmacognosy is a multidisciplinary science which plays a 
significiant role in the drug discovery and development.  The term 
pharmacognosy is derived from the Greek words “pharmakon” meaning 
drug and “gnosis” meaning knowledge. This term was first introduced by 
an Austrian physician Schmidt in 1811.23 The American Society of 
Pharmacognosy defines pharmacognosy as "the study of the physical, 
chemical, biochemical and biological properties of drugs, drug substances 
or potential drugs or drug substances of natural origin as well as the 
search for new drugs from natural sources." Ethnobotany, ethnomedicine, 
and ethnopharmacology are considered to be an integrative part of 
pharmacognosy.
Costaceae which consists of four genera, is one of the most 
recognized families of the order Zingiberales.
23 
24 It is differentiated from 
other families by their well-developed aerial shoots with a spiral 
phyllotaxy.24 Costus being the largest genus of this family, consists of 
more than hundred different species which are found in various tropical 
countries around the world.24,25 Around 5 species are seen in southeastern 
Asia.24
Costus pictus D. Don (synonym - Costus mexicanus Liebm.) is one 
of the medicinally important plants with its origin in South and Central 
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America.26 It is widely grown as an ornamental plant in Indian gardens, 
especially in Kerala.27 Costus pictus D. Don belongs to the family 
Costaceae and is differentiated from the Zingiberaceae family by the 
spirally arranged leaves and the absence of aromatic essential oils in its 
rhizomes.28 Because of the spiral arrangement of its leaves it is commonly 
referred as spiral ginger or step ladder.28 This plant has gained wide 
popularity in India as a low cost herbal remedy for diabetes.29 Fresh raw 
leaves of Costus pictus are chewed daily30 and are considered as a 
munching dietary supplement for diabetes.31 Though commonly used, no 
formulation of this plant is currently marketed.
4.1.1 Taxonomical hierarchy
31  
Kingdom  :  Plantae 
32 
Phylum  :  Magnoliophyta 
Class   :  Liliopsida 
Order   :  Zingiberales 
Family  :  Costaceae 
Genus   :  Costus  
Species  :  Costus pictus D. Don 
 
A recent phylogenetic analysis of the Costaceae family showed 
Costus is polyphyletic and the taxonomy has been revised. Three new 
genera have been seggregated from Costus: Paracostus, Cheilocostus and 
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Chamaecostus. Costus is now considered as a much smaller genus with 
restricted diversity.
4.1.2 Habitat and distribution 
24 
Costus pictus is a perennial herb which is native to Mexico.3 It is 
widely distributed along the coastal regions from Mexico to Costa Rica.5 
Costus pictus or spiral ginger7 is called by different local names in 
different regions. It grows in moist forests, hill forests, clearings, along 
waterways and roads at sea level of 300-1800 meters.3 It is also grown in 
various tropical countries and is recently introduced in India.5 It is grown 
widely in south Indian gardens and also runs wild in many places.
4.1.3 Growth and propagation
33 
Spiral ginger or spiral flag grows well either in full sun or partial 
shade. It requires fertile soil with adequate moisture and hence often 
planted near water sources. Propagation is usually done by the division of 
clumps, cuttings, or by separating the offsets and plantlets that form 
below the flower heads. 
34 
4.1.4 Morphological features of Costus pictus
Costus pictus is a perennial rhizomatous herb which has erect or 
spreading stems and grows to a height of 2-3 meters and spreads to 
around 1.5-2 meters. The leaves are simple, glossy, linear with wavy 
margins and are spirally arranged around the stem.  The narrow elliptic or 
obovate shaped leaves are subsessile and dark green in colour.   Globose 
 3,5,25,35-37 
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and ovoid inflorescences appear as terminal spikes around 3-8 cm in 
length. Ovate bracts forms a cone like structure which is green colored in 
exposed part and reddish in covered part.  The corollas are yellow with 
red stripes while the labellum is yellow. Anther is cream colored. Flowers 
do not produce any aroma. 
4.1.4.1 Macroscopic features of  Costus pictus leaf
Fruit is an ellipsoidal capsule.  
The leaves of Costus pictus are elliptical 7.9 – 15.5 cm long and 
3.8 – 5.7 cm broad. They are firm, flexible, and slightly succulent with 
entire margins and parallel venation. Apex is acute to acuminate and 
the base is subsessile to cuneate. Leaves are leathery to coriaceous in 
texture. They are dark green adaxially and light green abaxially. The 
leaves have no odour but are slightly sour to taste. They are arranged in 
a spiral (monostichous) fashion.  
35-37 
4.1.4.2 Microscopic features Costus pictus leaf
The leaves are amphistomatic with paracytic stoma. The following 
features can be seen in a transverse section of Costus pictus leaf: 
5 
a. Epidermis consisting of barrel shaped cells containing starch 
grains. Upper epidermis consists of simple unicellular, pointed non-
glandular trichomes.  
b. 2-3 layers of hypodermal parenchyma - below the upper epidermis 
and above the lower epidermis. Many crystalline inclusions were 
seen in most hypodermal cells.  
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c. Mesophyll containing spongy tissues (between hypodermal layers). 
The mesophyll consisted of closely packed cells containing starch 
grains. 
d. No palisade layer  
e. A single layer of sclerenchyma was seen enclosing the vascular 
bundle.  
4.1.5 Phytochemistry 
Around 18 chemical constituents have been identified and analyzed 
from Costus pictus leaves.
George et al.
28  
38 
Shiny et al.
performed phytochemical investigation of air dried 
leaves of Costus pictus. A preliminary physico-chemical analysis revealed 
high fibre content of the leaves (21.1%), which is essential in its activity 
against diabetes. A qualitative ash analysis of air dried leaves showed the 
presence of anions (carbonate, oxalate, chloride, phosphate and sulphate) 
and cations (sodium, potassium, magnesium and iron). Successive 
extractions of leaves with different solvents (petroleum ether, 
cyclohexane, acetone, ethanol) and its analysis showed presence of 
steroids in all the studied extracts. α-tocopherol present in ether fraction 
may be responsible for the antioxidant property of the leaf extract. 
39 performed phytochemical analysis of 24 different 
extracts yielded by two different extraction procedures – cold maceration 
and hot continuous extraction (soxhlet method). Hexane, ethyl acetate, 
methanol and aqueous extracts of leaves, stem and rhizomes were taken 
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for the analysis. The maximum extract yield was obtained from the leaves 
in both extraction procedures. Steroids, triterpinoids, alkaloids, phenols, 
glycosides, quinones, coumarins and flavanoids were found by 
preliminary phytochemical tests of extracts from different parts. Yield and 
concentration of phytochemicals and secondary metabolites was higher in 
the methanolic extract of leaf obtained from cold maceration method 
when compared to soxhlet method.  But the phytochemcial constituents 
were similar when obtained by these extraction methods which proved the 
absence of thermolabile consitutents in Costus pictus. The study also 
identified the presence of a glycoside (β- L- Arabinopyranose methyl 
glycoside) as the component responsible for the antidiabetic activity of the 
methanolic leaf extract. Another study by Shiny et al.29
Remya et al.
 revealed that the 
phytochemical content and their potent hypoglycemic activity of the 
Costus pictus plant was not altered by the environmental factors. 
5 studied the Costus pictus leaves for the presence of 
flavanoids, phenolic acids, quinones and steroids. Analysis of flavanoids 
and phenoilc acids were performed using spectrophotometry and 
chromatography techniques. The flavanoids identified were Kaempferol, 
4’- OMe- Kaempferol and 3’, 4’- di OMe-quercetin. The phenolic acids 
identified on chromatographic analysis were 2, 5-dihydroxy benzoic acid, 
3,5-dihydroxy benzoic acid, p-hydroxy benzoic acid, o-coumaric, cis and 
trans-p-coumaric acid,  vanillic, syringic, melilotic, α-resorcyclic and 
gentisic acids. The leaves also showed the presence of saponins, tannins, 
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quinones and steroids while glycoflavones and alkaloids were not detected 
in the analysis of leaves. 
Thomas et al.2 
Sulakshana et al.
performed the phytochemical analysis of hydro-
alcoholic extract of rhizomes of Costus pictus D. Don. The results 
confirmed that flavanoids, phenolic compounds, tannins, saponin 
glycosides, carbohydrates and steroids were present in detectable amounts 
in the studied extract.  
36 
A study by Jose et al.
studied to quantify the amount of diosgenin present 
in the rhizomes and leaves of different species of Costus (Costus pictus, 
Costus speciosus and Costus igneus) using HPLC method. Costus species 
are known to contain diosgenin (a steroidal saponin) as a major bioactive 
component. This study revealed higher percentage of diosgenin in Costus 
pictus when compared to the other two species. Rhizomes of Costus pictus 
(2.54%) had higher diosgenin content than its leaves (0.83%).  
26 analyzed the essential oils of the stems, leaves 
and rhizomes of Costus pictus. The constituents of essential oils of leaves 
were dodecanoic acid (3.96%), farnesyl acetone (7.04%), α‐ionone 
(8.01%), β‐ionone (8.69%), 2‐pentanol (22.48%) and hexadecanoic acid 
(24.51%). Hexadecanoic acid (palmitic acid), the major constituent of 
Costus pictus leaf oil, by enhancing the LDL to HDL ratio in healthy 
adults, can result in the development of coronary heart diseases. The study 
concluded that the long term use of Costus pictus leaves for the diabetic 
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treatment can result in serious cardiac diseases and hence could not be 
used as a standard anti diabetic treatment.  
4.1.6 Medicinal properties 
The decoction of Costus pictus stems and leaves are used in Cuba 
as a traditional medicine in the treatment of urinary infections, renal colic 
and renal lithiasis.3 Aerial parts of Costus pictus plant have been used as 
an infusion in Mexican folk medicine to treat kidney diseases5, 34 and was 
also known to possess diuretic activity.5 In India, especially Kerala, it is 
used as a herbal remedy for diabetes.2 The plant has been found to possess 
various other pharmacological activities like hypolipidemic, diuretic, 
antioxidant, antimicrobial and anticancer activities. Its aqueous extract has 
shown inhibitory effect on the formation of calcium oxalate monohydrate 
and hence prevents urolithiasis.  It has also been proved that its ethanolic 
extract has ameliorative effect on mitochondrial enzymes in alcohol 
induced oxidative stress.34
4.1.7 Toxicity studies 
  
Remya et al5 evaluated the acute toxicity of fresh aqueous leaf extract 
of Costus pictus on normal rats weighing 150-200 g in graded doses up to 
a maximum of 1g/Kg BW/day orally for 30 days. The study revealed that 
there was no effect on the appearance or general behavior of the animals. 
There were no untoward changes in food and water intake, body weight, 
body temperature and state of stool. No mortality was observed during the 
test period. 
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4.1.8 Pharmacological screening done with Costus pictus 
4.1.8.1 Analgesic and anti-inflammatory activity 
Moron et al3
Peripheral analgesic response was demonstrated using 0.75% acetic 
acid induced writhing in mice. Control animals received distilled water. 
Costus pictus decoction (30%) of fresh leaves and stems were used in 
doses of 0.5, 1.0 and 5.0 g fresh plant material / Kg body weight (BW); 
orally fed via gastric feeding tubes. The decoction decreased the 
number of writhes significantly and in a dose-dependent manner over 
an observation period of 15 minutes. The central analgesic response 
was demonstrated in mice by tail immersion method. The time to 
response (tail withdrawal) was recorded. Only the highest dose of plant 
decoction (5.0 g/Kg BW) significantly increased the time to tail 
withdrawal. The results of the above analgesic models used in the study 
proved a significant and dose dependent inhibition of central and 
peripheral pain responses by Costus pictus decoction. 
 evaluated the analgesic and anti-inflammatory 
activities of Costus pictus decoction (30%) of fresh leaves and stems. A 
phytochemical screening of Costus pictus decoction and identification 
of the secondary metabolites were also performed in this study.  
In the same study by Moron et al.3 the anti-inflammatory property 
of as Costus pictus decoction was evaluated using cotton granuloma 
model in male Sprague-Dawley rats. Cotton pellets (50 g) were 
implanted on the dorsal side of the body and the wound was sutured. 
  Review of Literature 
Page | 16  
 
Control group animals received sterile water. Test groups received 
aqueous extracts at doses of 0.5, 1.0 and 5.0 g fresh plant material / Kg 
BW in a single daily dose for four days.  On 5th day, animals were 
sacrificed and excision of granulomas was done. The granulomas were 
placed in a ventilated oven at a temperature of 150±10 ⁰C for three 
hours. Water content of the granuloma (wet weight minus dry weight) 
and fibrogranulosa content (dry weight of cotton pellet) in grams were 
assessed. The Costus pictus decoction did not modify significantly the 
water content; however the fibroganulosa content showed significant 
changes. This study thus demonstrated the lack of effect of Costus 
pictus decoction on inflammation induced by cotton granuloma model.
The phytochemical analysis detected the presence of phenolic 
compounds, flavanoids, coumarins, saponins, lactones and reducing 
sugars in the aqueous extract. The presence of significant amounts of 
these compounds were attributed to be responsible for its analgesic 
property.
3  
4.1.8.2 Antioxidant activity 
3 
Rege et al9 evaluated the in vitro antioxidant activity of fresh-
aqueous, fresh-hydroalcoholic, dry-aqueous and dry-hydroalcoholic 
extracts from fresh and dry leaves of Costus pictus using 1,1-diphenyl-
2-picryl hydrazyl (DPPH) assay. Freshly chopped or shade dried leaves 
were subjected for extraction. Hot decoction method was used to 
prepare aqueous extract while cold maceration using 20 % ethanol was 
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used for obtaining hydro alcoholic extract. Ascorbic acid at 
concentrations of 3-7 μg/mL was used as the standard. Among the four 
extracts studied, dry hydroalcoholic extract showed the strongest 
antioxidant activity. This study also assessed pepsin enzyme inhibitory 
activity of the extracts. All the extracts studied showed potent pepsin 
inhibitory activity, of which fresh-hydroalcoholic extract showed 
highest inhibition on pepsin enzyme activity.  
Rajasekaran et al8 studied the role of Costus pictus ethanol (CPE) 
extract against the oxidative stress caused by hyperglycemia in liver 
and kidney of alloxon administered rats. Glibenclamide (5 mg/Kg BW) 
was used as the standard drug for comparison. The CPE extract was 
administered orally in doses of 200 mg/Kg BW and 400 mg/Kg BW. 
The study revealed that the rats treated with CPE extract recovered 
from the altered antioxidant status due to hyperglycemia. GSH 
(reduced glutathione) levels were not significantly altered in both 
kidney and liver of CPE treated rats which indicate its protective role in 
oxidative stress. Also, protective effects of CPE extract on antioxidant 
enzymes [glutathione peroxidase (GPx), glutathione-s-transferase 
(GST), catalase (CAT), superoxide dismutase (SOD)] was noted in the 
kidney and liver tissues. High MDA level, an aldehyde product of lipid 
peroxidation in kidney and liver, is an indicator of oxidative stress 
induced by hyperglycemia. MDA being more stable and cytotoxic than 
reactive oxygen species (ROS) is an important marker enzyme for 
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oxidative stress severity. MDA levels were less affected in CPE 
administered rats. Also, there were no significant alterations in the 
marker enzymes (AST, ALT, ALP and LDH) in CPE treated rats. 
These were attributed to the protective role of the phytoconstituents of 
Costus pictus leaves against oxidative damage caused by 
hyperglycemia. With CPE treatment, glucose levels also returned to 
normal levels at the end of treatment period. This study confirmed the 
antioxidant and hypoglycemic potential of Costus pictus.  
Remya et al5 evaluated the antidiabetic activity of Costus pictus 
fresh leaf extract given orally to alloxan induced diabetic rats at doses 
of 100, 200, 400, 600 and 1000 mg/Kg BW for 60 days. The study 
concluded that there was a significant decrease in blood glucose levels, 
lipid profiles, urea, uric acid and creatinine at 200 and 400 mg/Kg BW. 
The effect at 400 mg/Kg BW was found to be equally effective as the 
standard drug Glibenclamide (600 μg/Kg BW). Treatment with fresh 
leaf extract significantly reduced TBARS levels in plasma, liver and 
kidney. There was also a significant increase in reduced glutathione 
(GSH) and vitamin C levels. The levels of SOD, CAT were raised 
while the levels of GPx were elevated in liver but reduced in kidney. 
The restoration of activity of these antioxidant enzymes after treatment 
with fresh leaf extract revealed its antioxidant potential. There were 
also changes in the levels of carbohydrate metabolizing enzymes. After 
treatment with extract, hexokinase activity was increased while activity 
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of glucose-6-phosphatase and fructose-1, 6-bisphosphatase was 
decreased which was comparable with the standard drug. The study 
claimed that these changes were due to increased insulin secretion 
stimulated by the treatment. The extract showed higher potency at a 
dose of 400 mg/Kg body weight. This study thus demonstrated that 
treatment with Costus pictus leaf extract resulted in prevention of 
glycation and improved the activity of enzymatic and non-enzymatic 
anti oxidants (decreased lipid peroxidation) along with a reduction in 
blood glucose levels. The doses of the leaf extract used in this study 
were found to be non-toxic as there were no significant changes after 
administration of the extract in normal rats.   
Suganya et al40 demonstrated that oral administration of aqueous 
extract of Costus pictus leaves (200 mg/Kg BW) to alloxan induced 
diabetic rats for 30 days showed significant reduction in blood glucose 
levels, urea, creatinine and increased the levels and activity of 
antioxidant enzymes. Administration of extract also resulted in 
significant increase in the concentration of total protein, albumin, 
globulin and A/G ratio. SGOT and SGPT levels were restored to 
normal levels after treatment with extract indicating restoration of 
normal liver functions. Also, reduced cholesterol and triglyceride levels 
were observed in the extract treated rats. The non toxic nature of the 
extract at the doses studied was confirmed with histopathological 
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studies of liver and pancreas which revealed a normal hepatic and 
pancreatic morphology.   
Sethumathi et al41 evaluated the antidiabetic and antioxidant 
activity of methanolic extracts of Costus pictus leaves administered 
orally as single daily dose of 120 mg/Kg BW and 180 mg/Kg BW in 
two different groups of alloxan induced diabetic rats. Tolbutamide (100 
mg/Kg BW) was used as the standard. The results showed significant 
reduction in blood glucose levels and lipid peroxidation. Treatment 
with the extract also resulted in significant increase in superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), 
glutathione reductase (GR), vitamin A, vitamin C, vitamin E and 
reduced glutathione (GSH) levels. SOD and CAT are considered as 
primary enzymes involved in free radical scavenging.  GPx in sufficient 
concentrations detoxifies H2O2. Vitamins A, C and E are powerful 
antioxidants by free radical scavenging or trapping. Reduction in 
TBARS levels of liver and kidney was noted in the extract treated 
diabetic rats. The reduced levels of total proteins in liver and kidney of 
the diabetic rats were restored to normal levels after treatment with the 
extract and these results were comparable with that of the standard 
drug. The author claimed that the methanolic extract of Costus pictus 
leaves possess free radical scavenging activity which was beneficial in 
restoring the pathological alterations caused by free radicals generated 
from lipid peroxidation process. The results were conclusive of the 
  Review of Literature 
Page | 21  
 
anti-hyperglycemic effects and antioxidant property of methanolic 
extracts of Costus pictus leaves. 
Sathuvan et al.42 
4.1.8.3 Antidiabetic activity 
confirmed the in vitro antioxidant potential of 
different fractions of bark of Costus pictus D. Don using various assays 
(DPPH radical assay, superoxide anion radical scavenging assay, nitric 
oxide radical scavenging assay, ferrous metal ion chelating ability, 
hydrogen peroxide scavenging assay and total reducing power). The 
total phenol and flavanoid content of different fractions of the extract 
were also determined. A secondary metabolite profile was done by 
TLC and the active components were further analyzed using GC-MS 
method. Phenolic compounds and flavanoids which are considered to 
be major antioxidants of plant sources were found to be higher in the 
extract. Among the different fractions studied, the chloroform bark 
extract of Costus pictus was shown to possess highest antioxidant 
activity.  
Jayasri et al4 studied the antidiabetic effect of aqueous extract of 
Costus pictus leaves (2 g/Kg BW) administered orally for 28 days in 
normal and streptozotocin induced diabetic rats. The results showed a 
significant reduction in fasting blood glucose and increase in the serum 
insulin levels. There was also significant increase in body weight of 
rats treated with the extract. Other parameters which showed significant 
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reduction were TBARS, urea, albumin, SGOT, SGPT, triglycerides and 
total cholesterol. With administration of aqueous extract to diabetic rats 
there was a significant increase in their body weights.  Phytochemical 
screening and trace element analysis of Costus pictus leaves were also 
done. The results revealed that Costus pictus leaves contain various 
phytochemicals like alkaloids, glycosides, carbohydrates, saponins, 
proteins and phenols and appreciable amounts of trace elements like Fe, 
Cu,  Mn, Ca, K, Cr and Zn. The study attributed the presence of these 
trace elements to be responsible for potentiating insulin activity. The 
non toxic nature of the extract was also confirmed from the 
histopathology sections of liver and kidney which revealed a normal 
architecture. The results were conclusive of the antidiabetic activity of 
the Costus pictus aqueous leaf extract. 
4.1.8.4 Hypolipidemic activity 
A study by Remya et al.5  revealed that oral administration of fresh 
leaf extract of Costus pictus (200 and 400 mg/Kg BW) significantly 
reduced plasma lipid levels (cholesterol, free fatty acid, phospholipids, 
triglycerides,  LDL, VLDL) while increased HDL levels. The reduction 
seen in the lipid profile was higher at a dose of 400 mg/Kg BW when 
compared to 200 mg/Kg BW. The study confirmed the hypolipidemic 
effect of the extract and this effect was directly correlated to the 
decrease in blood glucose levels.  
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Jayasri et al.4
4.1.8.5 Anthelmintic activity 
 in a study evaluating the antidiabetic effect of Costus 
pictus leaves in streptozotocin induced diabetic rats, has demonstrated 
that treatment with aqueous leaf solution of Costus pictus, caused 
significant decrease in levels of total cholesterol, triglycerides and 
lipids. The author attributed this effect on the lipid profile directly to 
the improved insulin levels as observed in this study. 
Thomas et al2 performed in vitro anthelmintic activity screening of 
hydro-alcoholic extracts of Costus pictus rhizomes against earthworms 
and compared with that of standard drug piperazine citrate  at varying 
concentrations (0.5, 0.75 and 1 g%).  It was shown in the study that the 
rhizome extract had significant anthelmintic activity. Time taken for 
complete paralysis after treatment with extract was comparable with the 
standard drug while there was significantly higher activity on death of 
worms when compared to that of the standard at the similar 
concentrations. A phytochemical evaluation of the hydroalcoholic 
extract of rhizomes was also carried out using a set of standard 
chemical tests as a part of this study. The results confirmed the 
presence of flavanoids, tannins, phenolic compounds carbohydrates, 
saponin glycosides and steroids. The study however did not show any 
correlation between the results of phytochemical constituents identified 
and the anthelmintic activity.  
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4.1.8.6 Antimicrobial activity 
Majumdar et al6
Reddy et al.
 tested the in vitro antibacterial activity of methanol 
and aqueous extracts of Costus pictus leaf, root, stem and flower 
against Escherischia coli, Shigella flexneri, Bacillus subtilis  and 
Klebsiella pneumonia, using agar well diffusion and broth dilution 
methods. A concentration of 150 μg/mL was used to determine the 
zone of inhibition and concentrations of 5-65 μg/mL was used to 
determine the minimum inhibitory concentration. The results proved 
that both aqueous and methanolic extracts of plant parts have inhibitory 
effect on the growth of the four tested microbes.  The inhibitory effects 
were significant for Escherischia coli, Shigella flexneri and Bacillus 
subtilis. However, at the concentrations used it was seen that there was 
no significant inhibitory effect on Klebsiella pneumonia. The inhibitory 
effects of methanolic leaf extract were higher than the aqueous leaf 
extracts against these three bacteria. The methanolic extract of root 
showed maximum inhibition against Shigella flexneri (MIC - 30 
μg/mL) while the flower extract was found to be highly sensitive 
against Klebsiella pneumoniae (MIC - 20 μg/mL). The antibacterial 
activity of the extracts was comparable with the standard antibiotics 
screened under similar laboratory conditions. 
33 evaluated the antibacterial activity of leaf essential 
oil of Costus pictus (1%, 5% and 10% concentrations) against ten 
pathogenic bacteria namely Staphylococcus aureus, Streptococcus 
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faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Escherichia coli, Salmonella paratyphi, Enterobacter faecalis, Bacillus 
cereus, Proteus vulgaris and Serratia marcescens using agar diffusion 
method. The study confirmed significant but varying degrees of 
antibacterial activity on the tested microbes and the results were 
comparable with standard antibiotics (ofloxacin, ciprofloxacin, 
tobramycin and gentamicin sulphate) when screened under similar 
conditions. The major components of the leaf essential oil such as fatty 
acids and ionones were attributed by the author for its antibacterial 
activity.  
Manjula et al.43
Sulakshana et al.
 evaluated the antibacterial property of leaves of 
Costus pictus D. Don. Heat Stable Proteins (HSP) and Total Soluble 
Proteins (TSP) analysis showed high HSP (0.9 mg/mL) and TSP (7.8 
mg/mL) content in leaves. The HSPs of the leaves of Costus pictus 
were extracted and used for evaluation of antibacterial activity against 
Staphylococcus aureus, Bacillus subtilis, Escherichia coli and 
Pseudomonas. The leaf protein extract revealed significant inhibition 
on all the tested bacteria, exhibiting maximum activity at a 
concentration of 100 µL/L. The results proved that the leaf protein 
extract of Costus pictus possessed significant antibacterial activity. 
7 evaluated the antibacterial activity of rhizome 
extracts (500-2000 μg) of three species of Costus (Costus speciosus, 
Costus pictus and Costus igneus) against gram positive bacteria 
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(Bacillus subtilis, Staphylococcus aureus) and gram negative bacteria 
(Escherichia coli, Pseudomonas aeruginosa). The antibacterial activity 
of the extracts was reported to be higher with increasing concentrations 
of the extract. The zone of inhibition diameter was found to be higher 
with Costus pictus extract against Staphylococcus aureus (1.26 cm), 
Pseudomonas aeruginosa (1.21 cm) and Escherichia coli (1.18cm). 
Bacillus subtilis showed the least zone of inhibition (1.12 cm). This 
study concluded that rhizome extracts of all three Costus species 
possessed potent antibacterial activity.  
4.1.8.7 Anticancer activity 
Sathuvan et al.42
Choudhury et al.
 performed in vitro evaluation of different 
fractions (chloroform, methanol soluble and methanol insoluble) of 
bark of Costus pictus for its cytotoxic effect on HT29 (colon cancer) 
and A459 (lung carcinoma) cell lines using MTT assay. The trypan 
blue dye exclusion test was used to assess the cell viability. Treatment 
of cell lines with varying doses of the extract fractions (50 µg -250 µg 
for 24 hours) showed a significant dose-dependent reduction in the 
viability of HT29 and A549 cells.  The total phenol and flavanoid 
content was also assessed in this study. The cytotoxic activity of the 
extracts against both the cell lines was attributed to the presence of 
flavanoids in these extracts.   
10 stuided the antiproliferative and apoptotic 
potential of Costus pictus on MOLT- 4 human cancer cell line (human 
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acute lymphoblastic leukemia) and normal cell line (human peripheral 
lymphocytes). Aqueous and alcoholic extracts at different 
concentrations were prepared from dried leaves of Costus pictus. 
Cytotoxicity was assessed by trypan blue dye exclusion test and MTT 
assay and the apoptic potential was analyzed by DNA fragmentation 
analysis of the treated cells. The ethanol extract of Costus pictus leaves 
was found to be highly cytotoxic (cell viability was less than 50% at 
120 μg/mL concentration) when compared to the aqueous and methanol 
extracts. The results of the study reported that the cytotoxicity was 
concentration dependent. The ethanolic extract also activated the 
apoptotic pathway in MOLT- 4 cells.  The same concentration was not 
cytotoxic to normal lymphocytes. This study confirmed the pro-
apototic and anticancer potential of the ethanol fraction of Costus 
pictus leaves.  
4.2 Oxidative stress  
An imbalance between oxidant and antioxidant mechanisms in our 
body results in oxidative stress in which free radical production can react 
indiscriminately to cause damage to almost any of the cellular component 
including carbohydrates, lipids, proteins, and DNA.17,18,22 Free radicals are 
continuously being produced endogenously as of part normal cellular 
functions or exogenously as a result of various environmental sources like 
pollutants, ultraviolet light, ionizing radiations, cigarette smoking, 
xenobiotics etc.44 Oxygen derivatives (superoxide anion, hydroxyl radical 
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and hydrogen peroxide) and reactive nitrogen species (nitric oxide and 
peroxynitrite) are the most important free radicals involved in various 
disease states like cardiovascular, autoimmune, diabetes mellitus, cancers, 
infectious and inflammatory conditions and nervous system disorders.
Antioxidants are the defense systems (endogenous or exogenous) 
which prevent free radical induced tissue damage by either preventing their 
formation, scavenging them, or by accelerating their degradation.
19,44 
42,44 They 
can be categorized into enzymatic antioxidants (superoxide dismutase, 
catalase, glutathione peroxidase, ceruloplasmin), transition metal binding 
proteins (tranferrin, ferritin, lactoferrin) and chain breaking antioxidants. 
The chain breaking antioxidants are further classified into lipid phase 
(tocopherols, carotenoids, flavonoids, ubiquinol) and aqueous phase 
(ascorbate, urate, glutathione and other thiols).44 Phytomedicines are good 
sources of natural antioxidants like carotenoids, ascorbic acid, 𝛼𝛼- 
tocopherol, flavonoids, and phenolic compounds.45
4.2.1 Role of oxidative stress in pain 
  
A study on 137 patients with acute and chronic inflammatory or non-
inflammatory back pain by Inamr et al. found out that the oxidative stress 
levels (as indicated by malondialdehyde (MDA) levels) were significantly 
higher in patients when compared to controls. This study however did not 
show any correlation for the levels of oxidative stress with pain severity 
and pain threshold.20 
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A study by Taha et al. revealed the role of oxidative stress in the 
pathogenesis of complex regional pain syndrome (CPRS). Nuclear factor 
erythroid 2-related factor (Nrf2) which is an important regulator of 
transcription of antioxidants has been proved to have anti nociceptive 
effects against inflammatory pain in an animal model. This study has also 
correlated the protective role of Nrf2 in clinical progression of CPRS.
Various studies suggest that oxidative stress may alter nociception by 
causing central and peripheral sensitization. Free radical production 
stimulates the sensory neurons and plays an important role in pain 
transmission.
19 
4.2.2 Role of oxidative stress in epilepsy 
20 
Brain is considered to be highly sensitive to oxidative damage.21 
Oxidative stress is an important underlying mechanism in the 
development and progression of various neurological diseases including 
epilepsy.45 A study by Dalton et al. was the first to reveal that the severe 
brain damage caused by treatment of brain with kainic acid in a rat model 
of epilepsy, was partly caused by oxidative stress.21
Free radicals produced as a result of oxidative stress may induce 
seizure activity either by increasing the concentration of excitatory 
neurotransmitter glutamic acid (result of direct inactivation of glutamine 
synthase) or by a decrease in the brain cortex content of inhibitory 
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neurotransmitter GABA (result of inhibition of enzyme glutamate 
decarboxylase by oxygen free radicals).45
Seizure induced free radical damage and mitochondrial dysfunction 
results in redox alteration and can lead to an increased seizure 
susceptibility and further development of subsequent epilepsy.
  
21,22,45 In the 
brain, enzymatic and non enzymatic antioxidants play a significant role in 
repairing oxidative damage. Of which, glutathione is considered to be the 
major antioxidant defense system in the brain.
Based on the evidence from animal models and clinical studies, anti 
oxidant therapies are recently being considered as an important 
therapeutic strategy in epilepsy,
22  
21,46  including those which are refractory 
to treatment with conventional antiepileptic drugs.
4.3 Methods of Screening for analgesic activity  
21,47 
Pain is an unpleasant symptom of almost every disease requiring 
appropriate and prompt treatment with analgesics (narcotics or non-
narcotics) which act either by central or peripheral mechanisms without 
affecting consciousness.11,48 Pain is a perception and a common 
phenomenon in all vertebrate animals and analgesic effects in animals are 
comparable to that in man.49 Pain constitutes an alarm system to limit the 
potentially damaging consequences of the underlying factor which caused 
the pain. The term nociception was derived from the Latin nocere, 
meaning “to harm”.49 Nociceptive refers to a stimulus that is capable of 
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producing a tissue lesion and evokes a reaction from the organism.49 
“Algogenic” refers to the capacity of a stimulus to produce pain, which 
include sensory, affective and motivational components.49 A “double 
pain” phenomenon is seen in humans after a brief nociceptive stimulus – 
“fast” pain (stinging and well localized) occuring as a result of activation 
of A δ fibres and “slow” pain (burning in nature, more intense, and more 
difficult to localize) which results from activation of C fibres and is 
slower in onset.
Pain evaluation is difficult in animals because of the absence of 
verbal communication, particularly when the animal does not exhibit a 
typical physical sign or overt behaviours. Physical signs are considered 
the most reliable signs of pain. Reactions to pain include basic motor 
responses (withdrawal, jumping, contractures, etc.), reactions with an 
increase in sympathetic tone (mydriasis, hyperpnea, tachycardia, arterial 
hypertension etc), and vocalization. Complex reactions to pain like 
behavioural responses - escape, distrust of objects responsible for painful 
experiences, avoidance, aggressiveness, modifications of behaviour 
(social, food, sexual, sleep, etc.) and passive motor responses (immobility 
allowing the animal to preserve a painless posture) are also often observed 
in animals.
12,50 
Animal models have their own limitations. Preclinical animal models 
may not adequately predict the clinical efficacy in humans because 
species differences can significantly alter the responses to 
49 
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pharmacological therapy.50 The inter species variations can also lead to 
wrong doses due to the pharmacokinetic differences.50 Large variations 
occur even in closely related species like that of rats and mice.50 Analgesic 
screening models commonly used look predominantly on evoked pain 
(experimental pain under controlled conditions) which may significantly 
vary from the actual clinical pain as seen in humans.
 
50 
 
Figure 1: Models for evaluating analgesic activity
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Figure 2: Models for evaluating central analgesic activity51-54
 
 
4.3.1 In vivo models for testing central analgesic activity
Animal models are still essential in analgesic research. Rodents (mice 
or rats) are most commonly used while in certain instances higher animals 
like monkeys are used. Different types of nociceptive stimuli (electrical, 
mechanical, thermal and chemical) are used in various animal models. 
48,51-54 
4.3.1.1 Models using mechanical stimulus
4.3.1.1.1 Haffner’s tail clip method
48,51-54 
48,51-54
This is a very sensitive model for screening centrally acting 
analgesics. Peripheral analgesics cannot be detected by this model. 
Hind paw and tail are the usually the preferred sites for applying 
nociceptive mechanical stimulus. An artery clip applied to the root 
of the tail is commonly used to induce acute pain. The animal 
usually responds immediately by biting the clip or the tail near 
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which the clip is placed.  Reaction time (time between clip 
application and response of the animal) is recorded using stop watch. 
Cut off time is calculated from the control group by taking the 
average reaction time plus three times the standard deviation of the 
combined latencies. The animals are observed till the cut off time. 
The cut off time of the test group is compared with that of the 
control and standard groups to determine whether there is any 
significant difference between the groups. If the reaction time of the 
test group is greater than the determined cut-off time, the test drug is 
said to have high analgesic effect.  
4.3.1.2 Models using thermal stimulus
In these models, only skin is stimulated without involvement of 
visceral or musculoskeletal tissues. The animal usually reacts by 
withdrawing itself quickly away from the thermal stimulus. These 
models are used to differentiate between the centrally acting opiate and 
non opiate analgesics. The response elicited in hot plate method is 
mostly at supraspinal level while the tail flick response is a 
predominant spinal response. These models are used to assess the 
threshold for response to a high intensity acute painful stimulus. 
Sedatives, psychotomimetics and muscle relaxants may produce false 
positive results by prolonging the reaction time.  
48,51-54 
 
  Review of Literature 
Page | 35  
 
4.3.1.2.1 Hot plate method
It is a widely used model to evaluate centrally acting analgesics. The 
thermal stimulus is used to induce acute pain. Since the paws of 
rodents are very sensitive to heat at temperatures not damaging the 
skin, paws are preferred for the evaluation. Animals are placed on a 
hot plate, which consists of an electrically heated surface (made of 
copper, iron or aluminium) which is maintained by the thermostat 
knob at a temperature range of 55 ⁰C to 56 ⁰C. The animals 
immediately respond by jumping, licking or withdrawal of paws. 
The latency period (the time between onset of stimulus and response 
of the animal) is recorded using stopwatch and is compared between 
the control, standard and test groups. The cut off time for 
observation is 15 to 20 seconds for mice and 20 to 30 seconds for 
rat.  
48,51-54 
4.3.1.2.2 Tail-Flick test
This model is a widely used and reliable test for evaluating opioid 
analgesics. Heat is used as noxious stimulus and the animal responds 
by flicking away its tail. The advantage of this model is that there is 
minimal inter animal variation. There are two variants of the tail-
flick test.  
48,51-53 
a. Application of radiant heat on to a small surface of tail 
b. Immersion of tail in water at a predetermined temperature 
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4.3.1.2.2.1 Radiant heat method
This model measures the drug-induced changes in the sensitivity of 
mice or rats to heat stress applied to their tails. Animals are placed 
into restrainers with their tails exposed. A light beam focused (radiant 
heat application) on the proximal third of the tail or a hot wire serves 
as the noxious stimulus. The reaction of each animal is observed for 
about 6 seconds. Mice with a reaction time of more than 6 seconds are 
not used in the test. Within few seconds the animal flicks the tail aside 
and rotates head and tries to escape [escape reaction]. Reaction time 
(time between radiant heat application and escape reaction) is 
recorded using stop watch. Lengthening of reaction time indicates 
analgesic activity of the test drug. In order to avoid severe injury to 
the tail, the cut off time is set as 15 to 20 seconds for mouse and 20 to 
30 seconds for rat.  
48,51-53 
4.3.1.2.2.2 Tail immersion method
Centrally acting analgesics are evaluated by this method. Rats or mice 
are used for this test. Each animal is placed in separate cage such that 
the tail hangs freely. The distal 5 cm is marked which is immersed in 
a cup filled with water at a temperature of 55 °C for a maximum time 
of 15 seconds. Reaction time (time for tail withdrawal reflex) is 
observed with a stop watch. Normal time for response is 1-5.5 
seconds. Drugs with central analgesic activity prolong the reaction 
time of the typical tail-withdrawal reflex in rats. Withdrawal time of 
48,51-54 
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more than 6 seconds in test group animals indicates analgesic activity 
of the test drug. 
4.3.1.3  Models using electrical stimulus
The advantages of these models are that they are non-invasive and 
the results produced are quantifiable and reproducible.  Well 
synchronized afferent signals are being produced. The disadvantages 
are that these stimuli are not a natural type of stimulus as encountered 
by animal in natural environment. Such stimuli excite all peripheral 
sensory fibres, which are not directly involved in pain. Thus, studies on 
peripheral transduction mechanisms are difficult with electrical 
stimulus. Variations can occur due to the differences in the impedances 
of tissues being stimulated.  
48,51,52,54 
4.3.1.3.1 Grid shock test
This test measures the analgesic properties by “Flinch-jump” 
procedure. This method was first described in mice by Blake et al.  
Rats or mice are used. Electric stimulus is applied via plastic 
chambers. Stainless steel wires, spaced about 1 mm apart are tightly 
wired on to the floor of the box. Square wave pulses at a frequency 
of 30 cycles per second are given for duration of 2 milliseconds per 
pulse. The stimulator output is connected to alternate wires of the 
grid. A fixed resistance is placed in series with the grid and in 
parallel to an oscilloscope to allow calibration in milliamperes. Paws 
of the rodents are usually preferred for application of the stimulus. 
48,51,52,54 
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Animals are placed individually in the plastic chamber and electrical 
stimuli of increasing intensities are applied and observed. With 
increasing shock intensities the animal will flinch, exhibit a startling 
reaction, locomotor activity increases or the animal attempts to 
jump. The behavior is recorded on an oscilloscope as marked 
fluctuations of the displayed pulse. Pain thresholds are determined 
for each individual animal. The current as measured in milliamperes 
is recorded for each animal before and after administration of the 
drug.  
Variations of this method: 
 Fractional escape procedure - animals are trained to press a 
lever to reduce the intensity of electrical stimulus delivered 
continuously through the floor grids of the experimental chamber. 
An external timer increases the intensity of the shock every few 
seconds. If the animal fails to press the lever, the shock continues 
to increase. Analgesic property of a drug is measured as the 
alteration in the level of shock which the rat will “tolerate”. 
 Pododolorimetry - Painful stimulation of the paws of mice 
placed into cages equipped with metal bands 
 An automated method to analyze vocalization of unrestrained rats 
after noxious stimuli. 
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4.3.1.3.2 Electrical stimulation of tail
Tail of mice is sensitive to any kind of stimulus. Electrical 
stimulation model has been first described by Burn et al. Variations 
in the duration or intensity of the electrical stimulus are used to 
observe the response. The effect of central analgesics and also the 
activity of peripheral analgesics at higher doses can be clearly 
demonstrated by this method. Mice are placed in special cages. A 
pair of alligator clips is placed on the tail. A positive electrode is 
placed on the tail at the proximal end. Rectangular wave pulses with 
an intensity of 40–50 V and frequency of 1 shock per second are 
delivered from a constant voltage stimulator for duration of 2.5 
milliseconds. Animal normally responds to the stimuli in 3 to 4 
seconds.  Following drug administration, the response time is 
observed and recorded every 15 minutes, until the reaction time 
returns to control levels. 
48,51,52,54 
Ultrasonic stimulation may be used instead of electrical stimulus. 
The advantage of this method is that it is fast, simple, and precise. 
Repeated stimuli can be used without causing tissue damage. 
4.3.1.3.3 Tooth pulp stimulation test
This method was first described by Kohl and Reffert (1938) and by 
Ruckstuhl and Gordanoff (1939) for testing central analgesic activity 
in rabbits, which was later adopted in several other species. This 
method is found to be highly sensitive for central analgesics, 
48,51,52,54 
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especially opioids. Non-opiate analgesics like ketamine and 
peripheral analgesics like pyrazolone derivatives also show positive 
response in this method. Characteristic reactions such as licking, 
biting, chewing and head flick which can be easily observed are 
induced by tooth pulp stimulation.  
Rabbits are commonly used. Animals are anaesthetized with 
thiopental (15 mg/Kg) or fentanyl citrate (0.2 mg/Kg) intravenously. 
Pulp chambers are drilled close to the gingival line in the lateral 
margins of the two front upper incisors using a high-speed dental 
drill. Before the experiment, the clamping electrodes are placed into 
the drilled pulp chambers. After thirty minutes, a rectangular current 
with a frequency of 50 Hz is given for duration of 1 second. The 
electrical stimulus is started with 0.2 milliamperes and increased 
until licking occurs to determine the threshold current. Threshold is 
determined at various pre determined time intervals with respect to 
drug administration.  
The intensity of threshold current, expressed in mV is used as an 
indicator of the intensity and duration of analgesic effect. Those 
drugs which produce an increase of the threshold versus the initial 
control by a factor of 2 or more is considered to possess anti 
nociceptive effect.  
Dogs and cats have been used instead of rabbits. Microinfusion 
of     bradykinin solution onto the tooth pulp of unrestrained rats is 
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used as a reliable method for evaluating analgesic effect of drugs on 
trigeminal pain.  
4.3.1.3.4 Monkey shock titration test
Analgesic tests in rodents (mice and rats) are closely correlated with 
analgesic activity of a drug in humans. Tests in higher animals like 
monkeys are necessary to clarify mode of action of test drug and to 
determine a suitable human dose. This model is not recommended for 
routine screening.  
48,51,52,54 
Monkeys are restrained in chairs and an electrical current is 
delivered by a Coulbourn Instrument Programmable Shocker through 
electrodes coupled to two test tube clamps. These electrodes are 
attached to a shaved portion of the monkey’s tail. The intensity of 
electrical stimulus is increased from 0 to 4 mA through 29 progressive 
steps and the monkey presses a bar to interrupt the shock. A stable 
baseline shock level is determined for each monkey on the day prior 
to drug administration. After administration of test drug, the change in 
maximum level of median shock intensity attained for drug is 
compared to control levels.   Monkey presses a bar to interrupt the 
shock. This is considered to the response. The shock intensity at 
which the animal produces the response is noted. The change in 
maximum level of median shock intensity for test drug is compared to 
control levels.  
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4.3.1.4 Models using chemical stimulus
Administration of algogenic agents represents a slow form of 
stimulation. Chemical stimulation is progressive and of longer duration, 
and once applied inescapable. These models do not measure the 
threshold but behavioral scores and are closest to clinical pain. 
48,51,52,54 
4.3.1.4.1  Formalin test in rats
This model is used as a chronic pain model which is sensitive to 
centrally active analgesic agents, whereas peripherally acting 
analgesics are almost ineffective. This method is useful to 
differentiate centrally acting morphine-like analgesics and non-
opiate analgesics and allows discrimination between inflammatory 
and non-inflammatory pain. 
48,51,52,54 
Wistar albino rats are commonly used. 0.05 mL of 10% formalin 
is injected into the dorsal portion of the front paw. The test drug is 
administered simultaneously either orally or subcutaneously. Each 
rat is placed individually into a clear plastic cage and observed. 
Scoring according to a pain scale is done at 30 and 60 minutes. 
Elevation or favouring of the paw or excessive licking and biting of 
the paw is considered as the response. Analgesic property of the test 
drug is indicated if both the paws are resting on the floor with no 
obvious favouring of the injected paw. 
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4.3.2 In vivo models for testing peripheral analgesic activity
Peripheral analgesics exhibit anti-inflammatory and antipyretic 
activity besides analgesia. The most commonly used methods for 
evaluating peripheral analgesic activity are the writhing tests in mice and 
the Randall-selitto test in rats. 
48,51,52,54 
 
4.3.2.1 Writhing tests
Pain is induced by injection of irritants like phenylquinone or acetic 
acid into the peritoneal cavity of mice. The animals react with a 
characteristic stretching behavior of abdomen with simultaneous 
stretching of atleast one hind limb which is called writhing. This model 
can be used to detect both central and peripheral analgesic activity. It is 
considered as a simple screening method. The limitation of this method 
is that it lacks specificity. Some psychoactive agents like haloperidol 
also show activity in this model.  
48,51,52,54 
Mice are commonly used. 0.25 mL of phenylquinone (0.02%) 
suspended in 1% carboxymethylcellulose is injected into the peritoneal 
cavity of mice. Each animal after drug administration is placed 
individually into glass beakers and after five minutes they are observed 
for a period of ten minutes and the number of writhes is recorded for 
each animal. Average number of writhes in each group and percent 
inhibition are calculated and recorded.  Percent inhibition is calculated 
by the formula given below: 
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      Average writhes (Control) – Average writhes (Test)
Average writhes (Control) 
 x 100 
If the value of the calculated percent inhibition is more than 70 %, 
the drug at that particular dose is considered to have significant 
analgesic activity.   
Intraperitoneal injections of other inducing agents used are 
acetylcholine, prostaglandin E1, aconitine, 4% sodium chloride 
solution, 7 mL air or 6% aqueous saline and ethacrinic acid. 
4.3.2.2 Randall-selitto test
This model is based on the principle that inflammation increases pain 
sensitivity which can be modified by analgesics. Inflammation 
decreases the threshold to pain while this threshold can be increased by 
non-narcotic analgesics and narcotic analgesics. Brewer’s yeast can be 
used to induce inflammation which increases pain after pressure. 
48,51,52,54 
Wistar albino rats are used. Subcutaneous injection of 0.1 mL of a 
20% suspension of Brewer’s yeast in distilled water into the plantar 
surface of the hind paw of the rat is used to induce inflammation. Three 
hours later, a special apparatus is used to apply pressure / force 
(measured in grams) at a constant rate to the plantar surface of rat’s 
foot till the animal struggles, squeals or attempts to bite. Each animal is 
tested individually for its control pain threshold and animals with 
threshold lesser than 80 g are included in the test.  The tests are done at 
intervals of 15 minutes after subcutaneous administration and at 
  Review of Literature 
Page | 45  
 
intervals of 30 minutes after oral administration for any change in pain 
threshold. The interval of time at which the increase in pain threshold is 
highest is considered as the peak time. The test drug is administered in 
a random manner. The pain threshold for the test drug is recorded at 
time zero and again at the pre-determined peak time (control value). 
The mean applied force is determined for each time interval. 
Percentage increase in pain threshold by the test drug is calculated as 
shown below: 
Applied force (Control) 
Applied force (test drug) - Applied force (Control) 
This model can detect both central and peripheral analgesics. 
Peripherally acting analgesics increase only the threshold of the 
inflamed paw, whereas opiate analgesics increase the threshold of the 
intact paw also. Commercially available Randall-Selitto analgesy 
meters can also be used.  
4.4  Methods of Screening for anticonvulsant activity 
Epilepsy is a chronic neurological disorder of disturbed electrical activity 
of the brain.14 It is widely prevalent throughout the world and associated 
with significant morbidity.55 Epilepsy is a collection of different types of 
seizures.  Prolonged and repetitive attacks significantly affect the quality of 
life and may be life threatening.14 They are often associated with depression, 
anxiety, neurodevelopmental delay, impairment of cognition and memory. 
Often these comorbidities are left unaddressed, and the treatment is usually 
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focused on seizure control alone.16 Epileptogenesis involves multiple 
heterogenous mechanisms.14,16 Epilpesy can occur due to alterations in 
voltage-dependent ion channels resulting either in decrease in inhibitory 
(GABA-mediated) inputs or increase in excitatory (glutamate mediated) 
inputs.15,16
Despite appropriate and adequate treatment with currently available 
antiepileptic drugs (AEDs), 25-40% patients are resistant to 
pharmacotherapy.
  
55 Though monotherapy may be effective in 50-70% of 
patients, seizure freedom is often achieved with combination therapy of anti 
epileptic drugs with different mechanisms of action.16 Complex 
pharmacokinetic interactions and drug induced adverse effects are important 
concerns with current antiepileptic therapy.15,16
Preclinical screening using animal models have played a crucial role in 
the discovery of various clinically effective AEDs. Most currently used 
models represent epileptic seizures rather than epilepsy as such.
  
55,56 The 
currently used animal models for epilepsy do not elucidate the mechanisms 
underlying preictal, interictal, ictal and postictal states. These are significant 
phases associated with behavioral changes in humans. Newer animal models 
are needed to address these limitations.
4.4.1 Methods of  screening antiepileptic drugs
56 
In vitro methods are –  
57,58 
 Electrical recording from isolated brain cells 
 In vitro assays for GABA receptor binding 
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 GABA uptake in rat cerebral cortex synaptosomes 
 GABA uptake and release in rat hippocampal slices 
 Excitatory amino acid (glutamate, glycine) receptor binding 
assays 
In vivo methods are –  
 Electrically induced seizure models 
 Chemically induced seizure models 
 Focal lesions induced seizure models 
 Models of status epilepticus 
 Models of infantile spasms 
 Genetic models of epilepsy 
4.4.2 Characteristics of an ideal model of epilepsy
None of the currently used animal model represents an ideal epilepsy 
model. An ideal animal model of epilepsy should reflect a similar 
pathophysiology as seen in humans and should also provide scope to 
assess the efficacy of the drug against pharmacoresistance.  The ability of 
a drug to modify progression of epilepsy following an insult should also 
be assessed. Following factors should be considered for an ideal animal 
model of human epilepsy: 
55 
 Pathological findings consistent with human epilepsy (e.g., cell 
loss, gliosis, neurogenesis, axonal and synaptic reorganization) 
 Latent period following initial insult which is species-appropriate  
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 Spontaneous seizures following latent period 
 Resistance seen with one or more antiepileptic drugs 
 Associated co-morbidities like progressive neurobehavioral and 
cognitive impairment 
4.4.3 In vivo models
4.4.3.1 Electrically induced seizure models
53,57,58 
These models are used to screen drugs which are effective for 
generalized tonic-clonic (grandmal) and focal seizures where as anti-
absence seizure drugs cannot be tested. Certain other centrally acting 
drugs also suppress the tonic hind limb extensions which are evoked by 
the electrical stimulus.  
53,57,58 
4.4.3.1.1 Maximal Electroshock induced Seizure (MES) model
Rats or mice are commonly used. A stimulating apparatus with 
corneal or ear electrodes supplying a constant current [50 mA for 
mice and 150 mA for rats] at a frequency of 50-60 Hz is applied for 
a duration of 0.2 seconds. A constant voltage of 250V (mice) or 
750V (rats) is used. The animals are observed for a period of 2 
minutes after application of electrical stimulus. The seizure which 
occurs passes through various phases: phase of tonic limb flexion, 
phase of tonic limb extension and a variable short clonic interval. 
Efficacy of new antiepileptic drugs is measured by the suppression 
of tonic hind limb extension.  
53,57,58 
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The limitations of this model are that though the eyes of the 
animals are moistened with a local anaesthetic before application of 
corneal electrodes, it has the risk of causing blindness. The variable 
short clonic interval may also cause asphyxial death in some 
animals. 
4.4.3.1.2 Threshold models
When used along with MES test, this model is useful to screen 
drugs which are effective against generalized tonic clonic seizures 
(GTCS). The drugs used in GTCS usually increase the seizure 
threshold. The drugs which increase the seizure threshold for tonic 
hind limb extension are considered to be effective.  
,57,58 
Mice or rats are commonly used for this experiment. Electrical 
stimulation is given by placing corneal or ear electrodes which 
delivers a constant current or voltage at a frequency of 50-60 Hz for 
0.2 seconds duration. Threshold is determined as the current or 
voltage which induces hind limb extension in 50% of the animals. 
Elevation of seizure threshold is taken as the measure of efficacy of 
the test drug. 
4.4.3.1.3 Kindling models
This is a model to develop seizures which involves delivery of 
repeated submaximal electrical or chemical stimulus. Progressive 
intensification of the stimulus, lowers the seizure threshold and results 
in a generalized seizure. Kindling demonstrates the fact that ‘epilepsy 
57,58 
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induces epilepsy’. Amygdala is the most commonly chosen region for 
kindling. The advantage of this model is that the efficacy of the drug 
can be measured against epileptogenesis as well as the fully kindled 
state. 
Adult Sprague-Dawley rats are used for this experiment. Electrical 
stimulation is done through an electrode placed in the right amygdala. 
After a recovery period of 1-2 weeks, daily electrical stimulus (400-
500 µA, 1 millisecond monophasic square wave pulses for 1 sec at a 
frequency of 50-60/second) is applied through the electrode. Daily 
electrical stimulation results in seizures, which evolve through 5 
stages: 
Class 1 – immobility, eye closure, twitching of vibrissae, 
stereotypic sniffing 
Class 2 – Facial clonus and head nodding 
Class 3 - Facial clonus, head nodding and forelimb clonus 
Class 4 – Rearing, often accompanied by bilateral forelimb clonus 
Class 5 – Rearing with loss of balance and falling accompanied 
by generalized clonic seizures 
Rats are considered fully kindled when class 5 seizures have 
developed. If stimulation continues for few weeks, rats develop 
spontaneous epileptic seizures. Four different measures for drug 
latency (seizure latency, seizure severity, seizure duration and after 
discharge duration) are recorded. 
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4.4.3.2 Chemically induced seizure models
a. Chemoconvulsants inducing generalized seizures after 
systemic administration - Pentylenetetrazole, bicuculline, 
picrotoxin, penicillin, isoniazid, thiosemicarbazide, 
allylglycine, strychnine, pilocarpine, N-methyl D aspartate, 
kainic acid, gamma hydroxybutyric acid, etc 
53,57,58 
b. Chemoconvulsants inducing focal seizures after central 
administration - Penicillin, kainic acid, quinolinic acid, 
pentylenetetrazole 
4.4.3.2.1 Pentylenetetrazole (PTZ) test
PTZ is a tetrazole derivative having a consistent effect in a large 
number of animal species. Its action is through inhibition of GABA 
neurotransmission. It is a useful and commonly used model for 
screening drugs effective against petitmal epilepsy or absence 
seizures.  
53,57,58 
Subcutaneous PTZ (scPTZ) test - Drugs effective in petit mal 
epilepsy like ethosuximide and valproic acid are effective in this 
model of epilepsy, while phenytoin and carbamazepine are 
ineffective. 
Rats or mice are used. CD97 of PTZ (Convulsive dose in 97% of 
the animals) is 70 mg/Kg in rats and 80-100 mg/Kg in mice. Control 
animals develop seizures within 30 minutes in a sequence of 
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excitement, myoclonic jerks, clonic seizures, one or more maximal 
clonic seizures and death. The first episode of clonic jerking lasting 
for 5 sec or the first clonic seizure with loss of righting reflex is 
taken as the end point.  
4.4.3.3 Focal lesions induced seizure models
 Seizures are induced with cortically implanted metals like 
alumina cream / gel, cobalt, tungstic acid or injection of iron 
into the brain cortex. Topical aluminium hydroxide gel model 
is most commonly used.  
57,58 
 Miscellaneous chemicals which are used to produce focal 
lesions are - intrahippocampal injections of kainic acid, topical 
applications of penicillin, cholinergics, picrotoxin, bicuculline, 
strychnine, zinc etc. 
 Systemic focal epipleptogenesis (model combining features of 
focal and generalized epilepsy) 
 
4.4.3.4 Models of Status Epilepticus
 Pilocarpine induced status epilepticus 
57,58 
 Lithium-pilocarpine induced status epilepticus 
 Lithium-methomyl induced seizures in rats 
 Electrical stimulation of hippocampal perforant pathway 
 D, L- homocysteine induced status epilepticus 
 Generalized myoclonic seizures in baboons 
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4.4.3.5 Genetic models
 Photosensitive baboons 
57,58 
 Seizure prone mice strains 
♦ Audiogenic seizure susceptible mice 
♦ Totterer mice 
♦ E1 mice 
♦ Quaking mice 
♦ Lethargic mice 
 Seizure prone rat strains 
♦ Genetically epilepsy prone rats 
♦ Rats with spontaneously occurring petitmal epilepsy 
 Mongolian gerbils 
 Miscellaneous genetically prone animals 
4.4.4 Widely used models in antiepileptic drug discovery 
MES and PTZ (scPTZ) seizure models are widely used in screening 
newer agents for their antiepileptic property. These are preferred because 
of the convenience in conducting the experiment, potential to screen large 
number of drugs, lesser investment and minimal expertise. MES model is 
considered to represent human generalized tonic-clonic seizures and 
scPTZ model is sensitive to screen AEDs for generalized absence 
seizures.55 MES model is not effective to screen drugs against partial 
seizures.59 MES and PTZ models though useful in initial screening of 
drugs with antiepileptic activity represent models of acute (reactive or 
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provoked) seizures rather than models for epilepsy.59 These models use 
non-epileptic animals. Acute seizure models may also be not useful in 
identification of drugs for pharmacoresistant seizures.59 MES model has 
also failed to prove efficacy of several novel AEDs like levetiracetam, 
tiagabine and vigabatrin.60 Though there are limitations, initial screening 
using simple animal models was crucial in the identification and 
development of all first and second generation AEDs except bromides and 
phenobarbital.
For drugs targeting prevention and modification of epileptogenesis, 
chronic seizure models like kindling and post-status models (pilocarpine 
or kainate models) are widely useful.
61 
61 Kindling is the only chronic model 
which has adequately predicted the clinical usefulness of novel AEDs 
againt partial seizures.60 Chronic models use epileptic animals which have 
been chronically induced electrically or chemically and those animals 
with inborn epilepsy. Though chronic models are labor intensive, they 
give more predictive data when compared to acute seizure models.
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5. Material and Methods 
5.1. Study design 
Experimental in vivo study in animals 
5.2. Study setting and duration 
The study was conducted over a time period of six months 
(December 2014 – May 2015) at the Research laboratory, Department of 
Pharmacology, Sree Mookambika Institute of Medical Sciences 
[SMIMS], Kulasekharam,   Kanyakumari District, Tamilnadu. 
5.3. Ethics committee approval 
The study was approved by the Institutional Animal Ethics 
Committee with reference number SMIMS/IAEC/2014/C/01 [dated 
29/09/2014]. 
5.4. Animals used 
5.4.1. Species 
Healthy adult Wistar albino rats of either sex, weighing between 
180-250 g were selected for the study. A total of 78 animals were 
obtained from the central animal house, Sree Mookambika Institute of 
Medical Sciences [SMIMS], Kulasekharam.  
5.4.2. Housing conditions
Adult Wistar albino rats of either sex were maintained in the 
central animal house of this institute as per the Committee for the 
62 
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Purpose of Control and Supervision of Experiment on Animals 
(CPCSEA) guidelines. Male and female rats were housed in separate 
cages. Pregnancy was excluded among the female rats before selection 
for the study. All the animals which were used for this study were fed 
with standard commercial rodent diet and water ad libitum. The 
animals were transferred to the research laboratory one week before 
the experiment for acclimatization. Three rats were placed in a single 
plastic cage at room temperature (27±2 ⁰C), humidity 70-80%, and 12 
hour light and dark cycle was maintained. All experiments were 
conducted between 10:00 AM and 4:00 PM to minimize the variations 
in the data obtained.  
5.5. Drugs and chemicals used 
A. Vehicle control – Sterile water  
B. Test drug – Hydroalcoholic extract of dried Costus pictus leaves. 
Doses used were 200 mg/Kg and 400 mg/Kg body weight. The doses 
were selected based on the previous studies done with Costus pictus 
leaves.
C. Standard drugs
5,40 
 For evaluating central analgesic activity - Morphine 
(Morphine sulfate – 10 mg/mL; MORPHITROY 10;  Troikaa 
Pharmaceuticals Ltd., Gujarat, India)  
51,52.57,58 
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 For evaluating peripheral analgesic activity - Diclofenac 
(Diclofenac sodium – 75 mg/mL; DICSOL-AQUA; Sunvet 
Healthcare, Himachal Pradesh, India) 
 For MES model - Diphenylhydantoin (Phenytoin sodium – 50 
mg/mL; EPTOIN; Akums Drugs and Pharmaceuticals Ltd., 
Haridwar, India) 
 For PTZ model - Sodium Valproate (Valproic acid – 100 
mg/mL; ENCORATE; Unimed Technologies Ltd., Gujarat, 
India)  
D. Drugs used to induce writhing51
 4% Sodium chloride – Sodium chloride salt for laboratory 
purpose (Thermo Fisher Scientific India Pvt. Ltd., Mumbai, 
India)  
  
E. Drugs used to induce convulsions57,58
 Pentylenetetrazole (PTZ) – (Sigma Aldrich, USA)  
  
F. Other drugs
 Lignocaine (Lignocaine Hydrochloride injection; LOX 2%; 
VHB Medi Sciences Limited, Uttarakhand, India) 
57,58 
5.6. Equipments used 
Artery clip, Eddy’s hotplate (Guna Enterprises, Chennai, India), 
electroconvulsiometer (MSK Private Ltd. Chennai, India), stop watch, 
beakers, stirrers, spatula, china dish, conical flask, water bath,  fine muslin 
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filter cloth, autoclave, refrigerator, airtight sterile container,  electronic 
weighing machine,  syringes (1, 3, 5 mL), oral feeding needle.  
5.7. Preparation of leaf extract 
5.7.1. Identification and authentication of Costus pictus leaves 
Costus pictus was identified and its leaves were collected during 
the month of November 2014, from a home garden at Nagercoil, 
Kanyakumari district, Tamilnadu. 
The Costus pictus leaves were authenticated by Botanist, 
Government Higher Secondary School, Karungulam, Thoothukudi 
District. The authenticated plant leaf was then kept as a specimen in 
the Museum, Department of Pharmacology, Sree Mookambika 
Institute of Medical Sciences, Kulasekharam, Kanyakumari district, 
Tamilnadu. 
5.7.2. Preparation of dry leaf powder
The collected Costus pictus leaves were washed with tap water 
and shade dried. The dried leaves were crushed into fine powder by 
mixer grinder. 
31,63 
5.7.3. Preparation of solvent 
50% hydroalcohol solution was prepared by mixing absolute 
alcohol and water (50:50, v/v) and 1000 mL of 50% hydroalcohol 
solution was prepared.  
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5.7.4. Preparation of hydroalcoholic extract of Costus pictus leaves 
The hydro-alcoholic extract was prepared by cold maceration 
method.63,64 Dried powder was weighed using electronic weighing 
balance. 100 g of the dried leaf powder was taken and it was mixed 
with 750 mL of hydroalcohol solution in a conical flask. The solution 
was stirred well so that no clumps were formed. The solution thus 
prepared was kept for one week with intermittent stirring. On 8th day, 
the solution was boiled at 50 ⁰C for 3 hours on a water bath. The 
solution was allowed to cool and was then filtered by using a fine 
muslin cloth. The powder which remained in the muslin cloth was 
again transferred into a conical flask and then mixed with 50% 
hydroalcohol solution and was used for the preparation of second 
batch of extract using the same procedure as mentioned above. The 
filtrate obtained was boiled at 90 ⁰C on water bath till the solvent got 
evaporated. A semi solid dark brown extract was obtained after 
condensation. The two batches of condensed extracts were mixed 
together and the whole extract was weighed. The obtained extract was 
heat sterilized in an autoclave at 121 ⁰C for thirty minutes.65 The 
extract was transferred to an airtight sterile container and was 
refrigerated for further use in the study. Required concentrations of the 
extract were freshly prepared just before the experiment by weighing 
appropriate amount of the stored extract and diluting it with sterile 
distilled water.  
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5.7.4.1. Yield 
For 100 g of dry leaf powder, 27.55 g of the condensed extract was 
obtained. (Yield = 27.55%) 
5.8. Study procedure 
The experiments were carried out as per the guidelines given by the 
Committee for the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA). An acclimatization period of one week was given 
before starting the study. All the animals were handled with utmost care to 
minimize the stress and pain. The animals used for the experiments were 
fasted overnight with free access only to water.  They were properly 
grouped and marked to avoid mixing of groups. 
5.8.1. Grouping of animals 
The animals used for the study were divided into thirteen groups 
[Group I to Group XIII], each consisting of six animals. A total of 78 
animals were used for this study. Of which, 30 animals were used for 
evaluating analgesic activity and 48 animals were used to evaluate 
anticonvulsant activity. Same animals [Groups I to IV] were used to 
evaluate analgesic activity sequentially using different models (Haffner’s 
tail clip method, hot plate method and writhing test) to reduce the 
number of animals used in the study. For writhing test, an additional 
positive control group [Group V] was used.  
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Table 1. Grouping of animals for evaluating analgesic activity51-53,6
Analgesic Activity 
6 
Group I Sterile water equivalent volume orally [Vehicle control for tail 
clip method, hot plate method and writhing test] 
Group II Morphine 5 mg/Kg BW intraperitoneally [Positive control for 
tail clip method, hot plate method and writhing test] 
Group III Costus pictus hydroalcoholic extract 200 mg/Kg BW orally [For 
tail clip method, hot plate method and writhing test] 
Group IV Costus pictus hydroalcoholic extract 400 mg/Kg BW orally [For 
tail clip method, hot plate method and writhing test] 
Group V Diclofenac sodium 12.5 mg/Kg BW orally [Positive control for 
writhing test] 
n=6 in each group; BW – Body Weight;  
 
Table 2. Grouping of animals for evaluating anticonvulsant activity57,58 
Electrically induced convulsions 
(With current 150 mA, at frequency 60 Hz, for duration 0.2 seconds) 
 
Group VI Sterile water equivalent volume orally [Vehicle control for MES 
model] 
Group VII Phenytoin 10 mg/Kg BW intraperitoneally [Positive control for 
MES model] 
Group 
VIII 
Costus pictus hydroalcoholic extract 200 mg/Kg BW orally [For 
MES model] 
Group IX Costus pictus hydroalcoholic extract 400 mg/Kg BW orally [For 
MES model] 
Pentylenetetrazole (70 mg/Kg BW, s.c) induced convulsions 
 
Group X Sterile water equivalent volume orally [Vehicle control for PTZ 
model] 
Group XI Sodium valproate 400 mg/Kg BW intraperitoneally [Positive 
control for PTZ model] 
Group XII Costus pictus hydroalcoholic extract 200 mg/Kg BW orally [For 
PTZ model] 
Group 
XIII 
Costus pictus hydroalcoholic extract 400 mg/Kg BW orally [For 
PTZ model] 
n=6 in each group  
BW – Body Weight; s.c – subcutaneous; mA – Milliamperes; Hz - Hertz  
MES – Maximal Elecroshock induced Seizures; PTZ – Pentylenetetrazole 
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5.8.2. Evaluation of analgesic activity
A total of five groups each consisting of six animals were used in 
the evaluation of analgesic activity. Each animal from groups I to group 
IV was individually tested in a sequential manner using different 
analgesic models. Haffner’s Tail clip method and hot plate method were 
done first to evaluate the central analgesic activity. The same animals 
were then subsequently subjected to writhing test for testing peripheral 
analgesic activity. For writhing test, an additional group (Group V) was 
used. Animals in group V received diclofenac sodium as the standard 
drug.  
51-53 
5.8.2.1. Central analgesic activity
5.8.2.1.1. Haffner’s tail clip method
51-53 
51-53 
Procedure: An artery clip was applied to the root of the rat’s tail 
(approximately 1 cm from the body) to induce acute pain. The 
vehicle control (Sterile water – equivalent volume) and the test 
drugs (hydroalcoholic extract of Costus pictus – 200 mg/Kg BW 
and 400 mg/Kg BW) were administered orally through oral feeding 
needles to the animals of the corresponding groups as shown in 
Table 1.  After 60 minutes of oral drug administration, each animal 
was tested individually by applying the tail clip. Animals of the 
standard drug group received morphine (5 mg/Kg body weight) 
intraperitoneally and 30 minutes later they were tested individually 
for the response.  
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Response: The animal normally responds to the noxious 
mechanical stimulus immediately within few seconds by biting the 
clip or the tail near the location of the clip. 
Cut off time: The animals were observed for response only till the 
cut off time. It was calculated using the mean reaction time of 
control group plus three times its standard deviation.54 
Evaluation:
5.8.2.1.2. Hot plate method
 The latency to react (time between stimulation onset 
and response) in seconds, was observed using stop watch and 
noted.  
51-53 
Procedure: Commercially available hot plate consisting of an 
electrically heated surface maintained at a temperature of 55 °C to 
56 °C, was used in this method. The vehicle control (sterile water – 
equivalent volume) and the test drugs (hydroalcoholic extract of 
Costus pictus – 200 mg/Kg BW and 400 mg/Kg BW) were 
administered orally to the animals of the corresponding groups as 
shown in Table 1. After 60 minutes of drug administration, each 
animal was placed individually over the preheated hot plate. 
Animals of the standard drug group were given morphine (5 
mg/Kg BW) intraperitoneally and 30 minutes later tested for 
response. The animals were observed for response till the cut-off 
time. 
  Material & Methods 
Page | 64  
 
Response: The animal usually responds to the heat stimulus by 
jumping, withdrawal of paws and licking of the paws.  
Cut off time: The cut off time taken was 30 seconds.  
Evaluation:
5.8.2.2. Peripheral analgesic activity
 The time until the above mentioned responses occur 
(reaction time) was noted in seconds, using a stopwatch. 
5.8.2.2.1. Writhing test
51,52,66 
51,52,66 
Procedure: Standard (Morphine - 5 mg/Kg BW; intraperitoneally 
and Diclofenac sodium -12.5mg/Kg BW; orally) and test drugs 
(hydroalcoholic extract of Costus pictus – 200 mg/Kg BW and 400 
mg/Kg BW) were administered orally to animals of the 
corresponding groups as shown in Table 1. Thirty minutes after 
intraperitoneal drug administration and sixty minutes after oral 
drug administration, writhing was induced with 4% NaCl (1 
mL/Kg) which was injected intraperitoneally.  Each rat was 
individually observed for the writhing response.  
Response: Writhing response (indicated by stretching of the 
abdomen with simultaneous stretching of at least one hind limb). 
Evaluation: The time for onset of writhes and the number of 
writhes in each animal was observed for a period of 30 minutes. 
Percent inhibition was calculated by the formula given below:
 
51 
Average writhes (Control) – Average writhes (Test) x 100     
           Average writhes (Control) 
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5.8.3. Evaluation of anticonvulsant activity
5.8.3.1. MES model
57,58 
57,58 
Procedure: The grouping of animals is shown in Table 2. The test 
drug (hydroalcoholic extract of Costus pictus – 200 mg/Kg BW and 
400 mg/Kg BW) was given orally and standard drug 
(diphenylhydantoin – 10 mg/Kg) was injected intraperitoneally (i.p). 
30 minutes after i.p injection and 60 minutes after oral 
administration, corneal electrodes were used to induce seizures.  
Before placing the electrodes, the eyes of the rats were moistened 
and anesthetized with lignocaine (2% solution). The 
electroconvulsiometer was set to deliver a stimulus of 150 mA 
intensity with a frequency of 60 Hz for duration of 0.2 seconds. 
Evaluation:
5.8.3.2. PTZ model
 Tonic hind limb extension (present/absent) and seizure 
activity scoring were observed for each animal.  
57,58 
Procedure: The grouping of animals is shown in Table 2. Each 
animal was weighed individually and the weights of the animals 
were noted. The test drugs (hydroalcoholic extract of Costus pictus – 
200 mg/Kg and 400 mg/Kg) were given orally and standard drug 
(Sodium valproate – 400 mg/Kg) was injected intraperitoneally (i.p). 
30 minutes after i.p injection and 60 minutes after oral 
administration, pentylenetetrazole was given in a dose of 70 mg/Kg 
subcutaneously. Each animal was then placed separately and 
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observed for one hour. Seizures and tonic convulsions were 
recorded. For each animal, time for onset of seizure, total number of 
seizures in one hour and duration of each seizure were noted. The 
total duration of seizure was obtained by adding up the duration of 
each seizure for an animal. The severity of seizures was also scored 
for each animal as mentioned below. 
5.8.4. Parameters 
A. ANALGESIC ACTIVITY:
i. Haffner’s tail clip  
51-53 
♦ Reaction time in seconds (time between onset of stimulus and 
response) 
ii. Hot plate method  
♦ Reaction time in seconds (time between onset of stimulus and 
response)  
iii. Writhing test (Writhing is indicated by stretching of the abdomen 
with simultaneous stretching of at least one hind limb)  
♦ Number of writhes in 30 minutes 
♦ Percent inhibition  was calculated by the formula given 
below
               
51 
Average writhes (Control) – Average writhes (Test)
Average writhes (Control) 
 x 100 
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B. ANTICONVULSANT ACTIVITY:
i. Maximal electroshock seizure (MES) model -  
53,57,58 
♦ Presence or Absence of Tonic Hind Limb Extension 
 Tonic Hind Limb Extension is a position when tail and 
both hindlimbs   are parallel to each other during an 
episode of generalized tonic clonic seizure. 
♦ Seizure activity scoring53 
 0 – No seizure 
(Score 0-4) as shown below: 
 1 – Forelimb extension without hindlimb extension 
 2 – Complete forelimb extension and partial hindlimb 
extension 
 3 – Complete tonic hindlimb extension 
 4 – Postictal depression 
♦ Percentage protection (%) calculated as follows 
Number of animals with THLE absent
Total number of animals 
 x 100 
 
ii.        Pentylenetetrazole (PTZ) model -  
♦ Onset of seizure activity (in seconds) 
♦ Total duration of seizure (in seconds) 
♦ Number of seizures in one hour 
♦ Severity of seizures53
 0.5 – Atypical behavioral changes (intense grooming, 
sniffing, moving arrests) 
 (Score 0-5) as shown below 
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 1 – Isolated myoclonic jerks, ear and facial twitching 
 2 – Atypical minimal seizures, convulsive wave through 
the body 
 3 – Fully developed minimal seizures, clonus of the head 
muscles and  fore limbs, righting reflex present 
 4 – Major seizures (generalized without tonic phase) 
 5 – Generalized tonic-clonic seizures beginning with 
running 
5.9. Statistical analysis 
 The data were entered into the Microsoft Office Excel 2007 for 
Windows 7 
 Data analysis was done using GraphPad Instat version 3.06, 32 bit 
for Windows [GraphPad Software, San Diego, California USA]  
 One-way ANOVA [Parametric test] followed by Bonferroni’s post 
hoc test was used for data with normal (Gaussian) distribution to find 
out the statistical significance between the study groups 
 Kruskal Wallis test [Non-parametric test] followed by Dunn’s post 
hoc test was used for data with non-normal (Non-Gaussian) 
distribution to find out the statistical significance between the study 
groups 
 P < 0.05 was considered as statistically significant 
 The results in bar diagrams are presented as Median ± SE [For 
scores] and Mean ± SE [For all other parameters] 
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6. Results:   
6.1. Animals used in study: 
        In this study, 78 adult healthy Wistar albino rats of either sex were used. All 
the above animals were categorized into 13 groups of 6 animals in each group. The 
grouping of animals has been shown in Table no: 1 and 2. 
6.2. Assessment of reaction time in tail clip model for evaluation of central 
analgesic activity: (Figure 3) 
   The study showed statistical significant increase in reaction time in Group II 
[P<0.001], Group III [P<0.01] and Group IV [P<0.001] when compared to Group 
I.  
The increase in reaction time in Group IV was comparable to Group II, as no 
statistically significant difference was found between these two groups [P>0.05]. 
Group III was not comparable to the standard Group II, as there was statistical 
significant difference found among these groups [P<0.001]. The study also showed 
that, there was statistical significant increase in reaction time in Group IV when 
compared to the Group III [P<0.01]. 
6.3. Assessment of reaction time in hot plate model for evaluation of central 
analgesic activity: (Figure 4) 
   The study showed statistical significant increase in reaction time in Group II 
[P<0.001] and Group IV [P<0.01] when compared to Group I.  
The increase in reaction time in Group IV was comparable to Group II, as there 
was no statistical significant difference between these two groups [P>0.05]. Group 
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III was found to be significantly different from standard Group II [P<0.001]. There 
was an increase in reaction time in Group III when compared to Group I, but it was 
not found to be statistically significant [P>0.05]. The study also showed that, there 
was significant rise in reaction time in Group IV when compared to the Group III 
[P<0.05]. 
 
6.4. Assessment of total number of writhes [in 30 minutes] in 4% Nacl 
induced model for evaluation of peripheral analgesic activity: (Figure 5) 
   The study showed statistically significant reduction in total number of writhes in 
Group II [P<0.01], Group IV [P<0.05] and Group V [P<0.01] when compared to 
Group I. There was decline in total number of writhes in Group III when compared 
to Group I, however it was not statistically significant [P>0.05]. 
   The decrease in total number of writhes in Group IV was comparable to Group II 
and Group V, as there was no statistical significant difference was found between 
these groups [P>0.05]. 
6.5. Assessment of percent inhibition of total number of writhes [in 30 
minutes] in 4% Nacl induced model for evaluation of peripheral analgesic 
activity: (Figure 6) 
   The percent inhibition of total number of writhes [in 30 minutes] in different 
groups includes Group I [0.00%], Group II [87.85%], Group III [68.23%], Group 
IV [82.87%] and Group V [85.36%]. 
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6.6. Assessment of scores of seizures in maximal electroshock seizure model: 
(Figure 7) 
   The study showed statistically significant decrease in scores of seizures in Group 
VII [P<0.001] and Group IX [P<0.001] when compared to Group VI. The decrease 
in scores of seizures in Group IX was comparable to the Group VII, as no 
statistical significant difference was found among these groups [P>0.05]. 
There was also decrease in scores of seizures in Group VIII when compared to 
Group VI, but it was not found statistically significant [P>0.05].  
6.7. Assessment of the percentage of protection of Tonic Hind Limb Extension 
[THLE] in maximal electroshock seizure model: (Figure 8) 
   In this study, all the animals in Group VI had tonic hind limb extension, 
however, none of the animals in Group VII, Group VIII and Group IX exhibited 
tonic hind limb extension. The percentage of protection of tonic hind limb 
extension in Group VII, Group VIII and Group IX was 100% in all these three 
groups.    
6.8. Assessment of onset of seizures in pentylenetetrazole model: (Figure 9) 
   The study showed statistical significant increase in onset of seizure time in 
Group XI [P<0.001] and Group XIII [P<0.001] when compared to Group X. The 
increase in onset of seizure time in Group XIII was comparable to Group XI, as 
there was no statistical significant difference between these two groups [P>0.05].  
There was a statistical significant difference between Group XI and XII [P<0.001]. 
There was also statistical significant difference found between Group XII and XIII 
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[P<0.01]. There was also increase in onset of seizure time in Group XII when 
compared to Group X, however it was not found statistically significant [P>0.05]. 
6.9. Assessment of duration of seizures in pentylenetetrazole model: (Figure 
10) 
   The study showed statistical significant decline in duration of seizure time in 
Group XI [P<0.001] and Group XIII [P<0.05] when compared to Group X. There 
was statistical significant difference between Group XII when compared to Group 
XI [P<0.05]. 
There was also decline in duration of seizure time in Group XII when compared to 
Group X, however it was not found  to be statistically significant [P>0.05].  
The decrease in duration of seizure time in Group XIII was comparable to Group 
XI, as there was no statistical significant difference found between these two 
groups [P>0.05].  
6.10. Assessment of number of seizures [in 1 hour] in pentylenetetrazole 
model: (Figure 11) 
   The study showed statistical significant reduction in number of seizures observed 
in 1 hour in Group XI [P<0.001] and Group XIII [P<0.05] when compared to 
Group X.  
There was also reduction in number of seizures in 1 hour in Group XII when 
compared to Group X, however it was not found statistically significant [P>0.05]. 
No statistical significant difference was found between Group XIII when 
compared to Group XI [P>0.05].  
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6.11. Assessment of scores of seizures in pentylenetetrazole model: (Figure 12) 
   The study showed statistically significant decrease in scores of seizures in Group 
XI when compared to Group X [P<0.01].  
There was also decrease in scores of seizures in Group XII [P>0.05] and Group 
XIII [P>0.05] when compared to Group X, however it was not found statistically 
significant. There was also decrease in scores of seizures in Group XIII when 
compared to Group XII, however it was not found statistically significant 
[P>0.05].  
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Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.001 when compared to group I 
#P < 0.01 when compared to group I 
$P < 0.001 when compared to group I 
P < 0.001 when compared to group II 
@P < 0.01 when compared to group III 
 
 
 
 
 
 
 
 
 
 
Group I: Sterile water equivalent volume orally [Vehicle control for tail clip method, hot plate 
method and writhing test]  
Group II: Morphine 5 mg/Kg body weight intraperitoneally [Positive control for tail clip method, 
hot plate method and writhing test]  
Group III: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For tail clip 
method, hot plate method and writhing test] 
Group IV: Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally [For tail clip 
method, hot plate method and writhing test] 
 
 
 
 
 
Figure 3. Bar diagram showing the reaction time [seconds] in tail clip model of central analgesic 
activity among different groups in Wistar Albino rats  
 
 
 
 
 
 
 
Data are analysed by One-way ANOVA with Bonferroni’s post-hoc test 
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Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.001 when compared to group I 
#P < 0.01 when compared to group I 
$P < 0.001 when compared to group II 
P < 0.05 when compared to group III 
 
 
 
 
 
 
 
 
 
 Data are analysed by One-way ANOVA with Bonferroni’s post-hoc test 
 
 
 
 
 
 
Figure 4. Bar diagram showing the reaction time [seconds] in hot plate model of central analgesic 
activity among different groups in Wistar Albino rats  
 
 
 
 
 
 
 
Group I:  Sterile water equivalent volume orally [Vehicle control for tail clip method, hot plate method 
and writhing test]  
Group II: Morphine 5 mg/Kg body weight intraperitoneally [Positive control for tail clip method, hot 
plate method and writhing test]  
Group III: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For tail clip method, 
hot plate method and writhing test] 
Group IV: Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally [For tail clip method, 
hot plate method and writhing test] 
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Figure 5. Bar diagram showing the total number of writhes in 30 minutes in 4% NaCl induced 
model of peripheral analgesic activity among different groups in Wistar Albino rats  
 
 
 
 
 
 
 
Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.01 when compared to group I 
#P < 0.01 when compared to group I 
$P < 0.01 when compared to group I 
 
 
 
 
 
 
 
 
 
 
Group I: Sterile water equivalent volume orally [Vehicle control for tail clip method, hot plate 
method and writhing test]  
Group II: Morphine 5 mg/Kg body weight intraperitoneally [Positive control for tail clip method, 
hot plate method and writhing test]  
Group III: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For tail clip 
method, hot plate method and writhing test] 
Group IV:  Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally 
Group V: Diclofenac sodium 12.5 mg/kg body weight orally [Positive control for writhing test] 
 
 
 
 
 
Data are analysed by non-parametric Kruskal Wallis test with Dunn’s post-hoc test 
 
 
 
 
 
 
* 
 
 
 
 
 
 
 
# 
 
 
 
 
 
 
 
$ 
 
 
 
 
 
 
 
  Results 
Page | 77  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.00
87.85
68.23
82.87 85.36
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
Group I Group II Group III Group IV Group V
Pe
rc
en
t I
nh
ib
iti
on
 (%
)
Figure 6. Line diagram showing the percent inhibition of total number of writhes in 30 minutes in 
4% NaCl induced model of peripheral analgesic activity among different groups in Wistar Albino 
rats  
 
 
 
 
 
 
 
n = 6 in each group 
% Inhibition was calculated by     Average writhes (Control) – Average writhes (Test) x100 
Average writhes (Control) 
 
 
 
 
 
 
 
 
 
 
Group I: Sterile water equivalent volume orally [Vehicle control for tail clip method, hot plate 
method and writhing test]  
Group II: Morphine 5 mg/Kg body weight intraperitoneally [Positive control for tail clip method, 
hot plate method and writhing test]  
Group III: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For tail clip 
method, hot plate method and writhing test] 
Group IV:  Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally 
Group V: Diclofenac sodium 12.5 mg/kg body weight orally [Positive control for 
writhing test] 
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Figure 7. Bar diagram showing the scores of seizures in Maximal Electroshock Seizure [150 mA 
current at frequency of 60 Hz, for duration of 0.2 sec] electrical model in Wistar Albino rats  
 
Data are represented as Median± SE 
 n = 6 in each group 
*P < 0.001 when compared to group VI 
#P < 0.001 when compared to group VI 
Score 0:    No seizure 
Score 1:    Forelimb extension without hindlimb extension 
Score 2:    Complete forelimb extension and partial hindlimb extension  
Score 3:    Complete tonic hindlimb extension [THLE] 
Score 4:    Postictal depression 
 
 
 
 
 
 
Group VI: Sterile water equivalent volume orally [Vehicle control for MES model]  
Group VII: Phenytoin 10 mg/kg body weight intraperitoneally [Positive control for MES model]  
Group VIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For MES model] 
Group IX: Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally [For MES model] 
 
 
 
Data are analysed by non-parametric Kruskal Wallis test with Dunn’s post-hoc test 
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Figure 8. Bar diagram showing the percentage of protection of Tonic Hind Limb 
Extension [THLE] in Maximal Electroshock Seizure [150 mA current at frequency of 
60 Hz, for duration of 0.2 sec] electrical model in Wistar Albino rats  
 
 
 
 
 
 
 
Data are represented as Percentage [%] 
 n = 6 in each group 
Percentage protection was calculated by   Number of animals with THLE absent x 100 
       Total number of animals 
 
 
 
    
 
 
 
 
 
 
 
Group VI: Sterile water equivalent volume orally [Vehicle control for MES model]  
Group VII: Phenytoin 10 mg/kg body weight intraperitoneally [Positive control for 
MES model]  
Group VIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally 
[For MES model] 
Group IX:  Costus pictus hydroalcoholic extract 400 mg/Kg body weight orally [For 
MES model] 
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Figure 9. Bar diagram showing the onset of seizures in a chemical model in Wistar Albino rats 
[Pentylenetetrazole 70 mg/Kg by subcutaneous route] 
 
 
 
 
 
 
 
Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.001 when compared to group X 
#P < 0.001 when compared to group X 
$P < 0.001 when compared to group XI 
P < 0.01 when compared to group XII 
 
 
 
 
 
 
 
 
 
 
Group X: Sterile water equivalent volume orally [Vehicle control for PTZ model]  
Group XI: Sodium valproate 400 mg/kg body weight intraperitoneally [Positive control for PTZ model]  
Group XII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
Group XIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
 
 
 
 
 
 
Data are analysed by One-way ANOVA with Bonferroni’s post-hoc test 
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Figure 10. Bar diagram showing the duration of seizures in a chemical model in Wistar Albino rats 
[Pentylenetetrazole 70 mg/Kg by subcutaneous route] 
 
 
 
 
 
 
 
Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.001 when compared to group X 
#P < 0.05 when compared to group X 
$P < 0.05 when compared to group XI 
 
 
 
 
 
 
 
 
 
 
Group X: Sterile water equivalent volume orally [Vehicle control for PTZ model]  
Group XI: Sodium valproate 400 mg/kg body weight intraperitoneally [Positive control for PTZ model]  
Group XII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
Group XIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
 
 
 
 
 
 
Data are analysed by non-parametric Kruskal Wallis test with Dunn’s post-hoc test 
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Figure 11. Bar diagram showing the total number of seizures in a chemical model in Wistar 
Albino rats [Pentylenetetrazole 70 mg/Kg by subcutaneous route] 
 
 
 
 
 
 
 
Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.001 when compared to group X 
#P < 0.05 when compared to group X 
 
 
 
 
 
 
 
 
 
 
Group X: Sterile water equivalent volume orally [Vehicle control for PTZ model]  
Group XI: Sodium valproate 400 mg/kg body weight intraperitoneally [Positive control for PTZ model]  
Group XII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
Group XIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
 
 
 
 
 
 
Data are analysed by non-parametric Kruskal Wallis test with Dunn’s post-hoc test 
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Figure 12. Bar diagram showing the scores of seizures in a chemical model in Wistar Albino rats 
[Pentylenetetrazole 70 mg/Kg by subcutaneous route] 
 
 
 
 
 
 
 
Data are represented as Mean ± SE 
 n = 6 in each group 
*P < 0.01 when compared to group X 
 
 
 
 
 
 
 
 
 
Group X: Sterile water equivalent volume orally [Vehicle control for PTZ model]  
Group XI: Sodium valproate 400 mg/kg body weight intraperitoneally [Positive control for PTZ model]  
Group XII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
Group XIII: Costus pictus hydroalcoholic extract 200 mg/Kg body weight orally [For PTZ model] 
 
 
 
 
 
Data are analysed by non-parametric Kruskal Wallis test with Dunn’s post-hoc test 
 
 
 
 
Score 0:     No behavioral changes 
Score 1:      Isolated Myoclonic jerks, ear and facial twitching 
Score 2:     Atypical minimal seizures, convulsive wave 
through the body 
Score 3:      Fully developed minimal seizures, clonus of head 
muscles & forelimbs, righting reflex present 
Score 4:      Major seizures [Generalized without tonic phase] 
Score 5:      Generalized tonic-clonic seizures beginning with 
running 
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7. Discussion 
The present study was aimed at evaluating the analgesic and 
anticonvulsant activities of hydroalcoholic extract of Costus pictus leaves in 
Wistar albino rats. Central analgesia models (Haffner’s tail clip and hot plate 
methods) and peripheral analgesia model (writhing test) were used in 
evaluation of analgesic effect of the test drugs in acute pain. Anticonvulsant 
effects of the test drugs were evaluated using electrically (MES model) and 
chemically (PTZ) induced acute seizure models.  
In both tail clip and hot plate methods, increase in pain threshold was seen 
at both the doses (200 mg/Kg BW and 400 mg/Kg BW) of CP-HALE.  400 
mg/Kg BW of the drug showed significantly higher increase in pain threshold 
and the effects were comparable with that of the standard drug used.  
Writhing test though lacks specificity, gives a good correlation with the 
clinical potencies of the evaluated analgesics.51 As opioid and non-opioid 
analgesics, antipyretics and NSAIDs can be effectively evaluated with 
relatively low doses using 4% NaCl, this was used in our study.51 The present 
study showed there was a significant decrease in the total number of writhes 
in 30 minutes with CP-HALE 400 mg/Kg BW and was comparable with both 
the standard drugs used in the study.  Compounds with percent inhibition of 
more than 70% are usually taken up for further dose ranging studies while 
those with less than 70% are considered as minimally active.51 The percent 
inhibition of CP-HALE (200 mg/Kg BW) was less than 70% [68.23%] while 
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with 400 mg/Kg BW of the drug it was greater than 70% [82.87%]. This 
result was comparable with both the standard drugs used (Morphine [87.85%] 
and Diclofenac sodium [85.36%]). This indicates that 400 mg/Kg BW could 
be a suitable dose taken for further studies for evaluating analgesic activites. 
The results obtained in our study are comparable with a study by Moron 
et al.3
The evaluation of CP-HALE for its anticonvulsant activity using MES 
model revealed that at both the doses (200 mg/Kg BW and 400 mg/Kg BW) 
there was 100 percent protection against tonic hind limb extension (THLE). 
A significant decline in the seizure scores was observed with 400 mg/Kg BW 
and this was comparable with the standard drug used. The decline in seizure 
scores was not significant at 200 mg/Kg BW administered dose. 
  in which the analgesic activity of decoction of fresh leaves and stems 
were tested in mice models (tail flick method and acetic acid induced 
writhing test) and their results revealed a significant dose dependent pain 
inhibition.  
In pentylenetetrazole (PTZ) model, CP-HALE at both the doses increased 
the time for onset of seizures and decreased the duration of seizures. These 
effects observed were higher and significant at 400 mg/Kg BW dose which 
was comparable to the standard drug used. There was also a significant 
reduction in the total number of seizures (in one hour) with CP-HALE 400 
mg/Kg BW in the PTZ model. There was no significant decline in the seizure 
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scores of PTZ model with CP-HALE at both the doses (200 mg/Kg BW and 
400 mg/Kg BW).  
Free radicals are being implicated in the development and progression of 
various physiological and pathological states including pain and epilepsy.18,19 
Phytomedicines which are rich sources of antioxidants could have a 
significant therapeutic potential in their management. Flavanoids and 
phenolic compounds are the important antioxidants derived from plant 
products.45 Particularly, flavanoids are considered to be ideal free radical 
scavengers and are even more efficient than vitamins C and E.
Various parts of Costus pictus have been proved to have antioxidant 
property by several previous studies.
18 
5,8,9 Phytochemical analyses in earlier 
sstudies with  Costus pictus have revealed the presence of flavanoids.2,5,39 
Solvent extraction is the most commonly used procedure to obtain active 
principles from plant sources, particularly antioxidants.67 In a previous study 
by Rege et al.9
GABA is a major inhibitory neurotransmitter and an important target of 
several conventionally used antiepileptic drugs.
 it was shown that dry hydroalcoholic extract of Costus pictus 
leaves had highest antioxidant activity when compared with other leaf 
extracts. Since antioxidant property is being hypothesized for its analgesic 
and anticonvulsant potential, hydroalcoholic extract prepared from dried 
leaves was chosen for this study.  
45 Potentiation of GABA 
receptor is protective against MES and PTZ induced seizures. 45,68,69,70 PTZ 
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induced seizures mimics a state of increased oxidative stress in the brain.45 
Flavanoids have been found to modulate GABAA-Cl channel complex and 
also increase the seizure threshold.45,68,69
All precautions to minimize bias due to gender or diurnal variations were 
taken. Male and female rats were equally distributed among the groups to 
minimize gender variations on the results. Pregnancy was excluded in female 
rats before inclusion into the study. All experiments were conducted during 
the same hours on all days to minimize diurnal variations.  
 Hence, flavanoids by its potent 
antioxidant and anticonvulsant activity might be responsible for the 
significant effects as seen in our study.  
MES and subcutaneous PTZ (scPTZ) seizure models are the commonly 
used models to evaluate the effects of a drug on acute seizures.55 MES model 
is representative of grandmal epilepsy and scPTZ model represents 
generalized absence seizures in humans.55 In this study, animal models and 
drugs (phenytoin for MES model and sodium valproate for PTZ model) as 
prescribed by standard protocols were used.51 In particular, since PTZ is a 
GABA antagonist, PTZ model is sensitive to GABA mimetic drugs.45 
Oxidative stress had been the basis for hypothesis for the analgesic and 
anticonvulsant activity of the Costus pictus hydroalcoholic extract. But this 
Since 
the proposed activity of our study extract may be due to the presence of 
flavanoids which modulates GABA, the PTZ model used in our study is very 
relevant.  
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study did not include any markers for evaluating the oxidative stress levels or 
restoration of antioxidant levels.   
MES and PTZ models are acute seizure models.55 Since epilepsy is a 
chronic condition requiring daily drug administration,14
Our present study has thus confirmed that Costus pictus hydroalcoholic 
extract at 400 mg/Kg BW had better analgesic and anticonvulsant activity 
when compared to the 200 mg/Kg BW dose. Further animal studies using 
different models and larger clinical trials are needed to confirm these results.  
 chronic drug 
administration could yield different results.  Hence further studies with 
chronic models like kindling models are needed for more predictive data. 
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8. Conclusion 
The hydroalcoholic extract of Costus pictus leaves possess significant 
central and peripheral analgesic activity in Wistar albino rats at the dose of 
400 mg/Kg BW.  
Significant anticonvulsant activity on electrically induced and 
pentylenetetrazole induced seizures in Wistar albino rats is seen with 
hydroalcoholic extract of Costus pictus leaves at the dose of 400 mg/Kg BW. 
 
 
  
 
  
 
 
 
 
 
 
  
 
SUMMARY 
  Summary 
Page | 90  
 
9. Summary 
Plants are widely researched in search of new drugs since ancient times 
and there is a re-emerging interest on phytomedicines.1 Limitations seen with 
the currently available drugs have always brought forth the need for a well 
tolerated analgesic and antiepileptic drug. Oxidative stress is an important 
underlying pathophysiologic process in pain and epilepsy.18,19 Costus pictus 
widely grown as an ornamental plant is very popular for its various 
medicinal properties. Costus pictus has proven evidence in literature to have 
antioxidant property.5,8,9 A study had particularly shown that the 
hydroalcoholic extract of Costus pictus obtained from dried leaves has a very 
high antioxidant potential9
A total of 78 Wistar albino rats of either sex were used in this study. The 
central analgesic activity of the hydroalcoholic extract of Costus pictus 
leaves (CP-HALE at doses of 200 mg/Kg BW and 400 mg/Kg BW) was 
evaluated using the tail clip and hot plate methods. CP-HALE was found to 
increase the pain threshold at both the doses. This effect was highly 
significant with 400 mg/Kg BW. The peripheral analgesic property was 
assessed using 4% NaCl induced writhing test, which revealed that CP-
HALE (400 mg/Kg BW) showed highly significant reduction in number of 
writhes observed in 30 minutes and the percent inhibition was greater than 
70%. This showed that CP-HALE 400 mg/Kg BW had good peripheral 
 and this was the basis for our hypothesis. Our 
study was thus aimed to evaluate the analgesic and anticounvulsant 
properties of Costus pictus using appropriate models in Wistar albino rats. 
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analgesic activity which was comparable to the standard drugs used in the 
study. 
Anticonvulsant properties were tested using MES and PTZ models which 
revealed better activity with CP-HALE 400 mg/Kg BW. Both the doses (200 
mg/kg BW and 400 mg/Kg BW) showed 100% protection against tonic hind 
limb extension induced by MES model. In PTZ model, treatment with CP-
HALE prolonged the time to onset of seizures, significantly decreased the 
duration of seizures and the total number of seizures in one hour. These 
effects were highly significant with CP-HALE 400 mg/Kg BW. This has 
brought forth the fact that CP-HALE 400 mg/Kg BW has good 
anticonvulsant activity and is comparable with the standard drugs used.  
Flavanoids with a very high antioxidant potential have been found in 
various extracts of Costus pictus by several earlier studies.2,5,39 Also, 
flavanoids have been found to modulate GABAA-Cl channels which might 
be responsible for its anticonvulsant potential.45,68,69  Hence the analgesic and 
anticounvulsant effects seen in our study could be attributed to the presence 
of flavanoids in the hydroalcoholic extract of Costus pictus leaves. From the 
results of our study it can be concluded that hydroalcoholic extract of Costus 
pictus leaves (CP-HALE 400 mg/Kg BW) possess significant analgesic and 
anticonvulsant activity.  Hydroalcoholic extract of Costus pictus leaves (400 
mg/Kg BW) can be taken up for further larger animal and human studies for 
more predictive results. 
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Image 1: Costus pictus plant 
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Image 2: Authentication of Costus pictus leaf 
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Image 3: Hydroalcoholic extract of Costus pictus leaves 
 
 
 
 
Image 4: Drugs used for evaluating analgesic activity 
 
 
 
 
 
 
  Annexures 
Image 5: Electroconvulsiometer 
 
 
 
Image 6: Drugs and chemicals used for evaluating anticonvulsant activity 
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DPPH 1,1-diphenyl-2-picryl hydrazyl 
Fe Iron 
g Grams 
GABA Gamma Amino Butyric Acid 
GC-MS Gas Chromatography Mass Spectrometry 
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GST Glutathione-S-Transferase 
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HDL High Density Lipoprotein 
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ROS Reactive Oxygen Species 
s.c Subcutaneous 
scPTZ Subcutaneous Pentylenetetrazole 
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TSP Total Soluble Proteins 
V Volts 
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